<?xml version="1.0" encoding="us-ascii"?>
<!-- Prepared by Clarity FSR  v6.6.0.454 using Fujitsu Interstage XWand -->
<xbrli:xbrl xmlns:ci="http://www.cigna.com/20120331" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:us-roles="http://fasb.org/us-roles/2011-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <link:schemaRef xlink:type="simple" xlink:href="ci-20120331.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://xbrl.fasb.org/us-gaap/2011/elts/us-types-2011-01-31.xsd" />
  <link:schemaRef xlink:type="simple" xlink:href="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd" />
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Apr16_2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-04-16</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_DefinedBenefitPensionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:DefinedBenefitPensionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_ComponentsOfPensionAndOtherPostretirementBenefitsAxis_OtherPostretirementBenefitPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ComponentsOfPensionAndOtherPostretirementBenefitsAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_HealthCareSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:HealthCareSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:DisabilityAndLifeSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_DisabilityAndLifeSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:DisabilityAndLifeSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_RunOffReinsuranceSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:RunOffReinsuranceSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_RunOffReinsuranceSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:RunOffReinsuranceSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_OtherOperationsSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_OtherOperationsSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:OtherOperationsSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_CorporateSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:CorporateSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_CorporateSegmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:CorporateSegmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel3Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel3Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis_FairValueInputsLevel1Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">ci:EffectOfDilutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareDilutedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareBasicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">ci:EffectOfDilutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareDilutedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:EarningsPerShareBasicDilutedByCommonClassAxis">us-gaap:EarningsPerShareBasicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2010_TO_Dec31_2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_EstimateOfFairValueFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011_ci_FairValueFinancialInstrumentsNotCarriedAtFairValueAxis_CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueFinancialInstrumentsNotCarriedAtFairValueAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue20175375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20175375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue20175375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20175375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2018635InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue2018635InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2018635InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue201985InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue201985InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue201985InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20205125InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue20205125InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20205125InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue20224InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20224InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue20224InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20224InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue2023765InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue2023765InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2023765InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue202383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue202383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue202383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_DebenturesDue20277875InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_DebenturesDue20277875InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:DebenturesDue20277875InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_StepDownNotesDue203383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:StepDownNotesDue203383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_StepDownNotesDue203383InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:StepDownNotesDue203383InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue2036615InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue2036615InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2036615InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_OtherLongTermDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:OtherLongTermDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_OtherLongTermDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:OtherLongTermDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20204375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue20204375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20204375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue202145InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue202145InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue202145InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue202145InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue20415875InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20415875InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue20415875InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20415875InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_TotalSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:TotalSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_TotalSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:TotalSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_PurchasedOptionsGmibAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:PurchasedOptionsGmibAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_PurchasedOptionsGmibAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:PurchasedOptionsGmibAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_us-gaap_DerivativeInstrumentRiskAxis_WrittenOptionsGmibLiabilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:WrittenOptionsGmibLiabilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_us-gaap_DerivativeInstrumentRiskAxis_WrittenOptionsGmibLiabilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:WrittenOptionsGmibLiabilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_GuaranteedMinimumIncomeBenefitsFairValueGainLossMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_us-gaap_DerivativeInstrumentRiskAxis_WrittenOptionsGmibLiabilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:WrittenOptionsGmibLiabilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_GuaranteedMinimumIncomeBenefitsFairValueGainLossMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_us-gaap_DerivativeInstrumentRiskAxis_WrittenOptionsGmibLiabilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:WrittenOptionsGmibLiabilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_GuaranteedMinimumIncomeBenefitsFairValueGainLossMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_us-gaap_DerivativeInstrumentRiskAxis_PurchasedOptionsGmibAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:PurchasedOptionsGmibAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_GuaranteedMinimumIncomeBenefitsFairValueGainLossMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_us-gaap_DerivativeInstrumentRiskAxis_PurchasedOptionsGmibAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:GuaranteedMinimumIncomeBenefitsFairValueGainLossMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:PurchasedOptionsGmibAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumDeathBenefitsEquityFuturesMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumDeathBenefitsEquityFuturesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumIncomeBenefitsEquityFuturesMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumIncomeBenefitsEquityFuturesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumDeathBenefitsEquityFuturesMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumDeathBenefitsEquityFuturesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumIncomeBenefitsEquityFuturesMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumIncomeBenefitsEquityFuturesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateSwapGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_InterestRateFuturesGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateSwapGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_DerivativeInstrumentRiskAxis_InterestRateFuturesGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateSwapGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_InterestRateFuturesGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateSwapGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_DerivativeInstrumentRiskAxis_InterestRateFuturesGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_NotionalHedgedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:NotionalHedgedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_NotionalHedgedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:NotionalHedgedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_NotionalHedgedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:NotionalHedgedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_NotionalHedgedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:NotionalHedgedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_NotionalHedgedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:NotionalHedgedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_NotionalHedgedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:NotionalHedgedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:OtherLongTermInvestmentsDesignatedAsAccountingHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_DerivativesDesignatedAsAccountingHedgesAxis_AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">ci:AccountsPayableAccruedExpensesAndOtherLiabilitiesDesignatedAsAccountingHedgeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_ForeignCurrencySwapMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:ForeignCurrencySwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_HedgingDesignationAxis_DesignatedAsHedgingInstrumentMember_us-gaap_DerivativeInstrumentRiskAxis_InterestAndForeignCurrencySwapsMember_ci_DerivativesDesignatedAsAccountingHedgesAxis_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestAndForeignCurrencySwapsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesDesignatedAsAccountingHedgesAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember_us-gaap_DerivativeInstrumentRiskAxis_WrittenOptionsGmibLiabilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:WrittenOptionsGmibLiabilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember_us-gaap_DerivativeInstrumentRiskAxis_WrittenOptionsGmibLiabilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:WrittenOptionsGmibLiabilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember_us-gaap_DerivativeInstrumentRiskAxis_PurchasedOptionsGmibAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:PurchasedOptionsGmibAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember_us-gaap_DerivativeInstrumentRiskAxis_PurchasedOptionsGmibAssetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:PurchasedOptionsGmibAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningEquityMarketVolatilityImpactsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis">ci:GuaranteedMinimumDeathBenefitReserveStrengtheningEquityMarketVolatilityImpactsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningInterestRateImpactsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis">ci:GuaranteedMinimumDeathBenefitReserveStrengtheningInterestRateImpactsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningOverallMarketDeclineImpactsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis">ci:GuaranteedMinimumDeathBenefitReserveStrengtheningOverallMarketDeclineImpactsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Oct01_2009_TO_Dec31_2009">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-10-01</xbrli:startDate>
      <xbrli:endDate>2009-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ParentMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_CommonStockMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ParentMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio120xTo129xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio120xTo129xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio110xTo119xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio110xTo119xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio100xTo109xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio100xTo109xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatioBelow50PercentMemberMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatioBelow50PercentMemberMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio50PercentTo59PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio50PercentTo59PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio60PercentTo69PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio60PercentTo69PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio70PercentTo79PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio70PercentTo79PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio80PercentTo89PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio80PercentTo89PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio90PercentTo99PercentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio90PercentTo99PercentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatioLessThan100xMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatioLessThan100xMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansReservesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansReservesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansReservesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansReservesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansReservesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansReservesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansReservesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansReservesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_ImpairedCommercialMortgageLoansRelatedValuationReservesAxis_CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember_ci_ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis_ImpairedCommercialMortgageLoansNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansRelatedValuationReservesAxis">ci:CommercialMortgageLoansFinancingReceivableWithNoRelatedAllowanceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:ImpairedCommercialMortgageLoansAndRelatedValuationReservesAxis">ci:ImpairedCommercialMortgageLoansNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FairValueByAssetClassAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FairValueByAssetClassAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2010_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_FairValueByAssetClassAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_FairValueByAssetClassAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_FairValueByAssetClassAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_FairValueByAssetClassAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis">ci:InternationalSegmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_InvestmentValuationComponentsAxis_PortionAtAmortizedCostDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:PortionAtAmortizedCostDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_InvestmentValuationComponentsAxis_PortionAtAmortizedCostDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:PortionAtAmortizedCostDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_InvestmentValuationComponentsAxis_UnrealizedGainMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:UnrealizedGainMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_InvestmentValuationComponentsAxis_UnrealizedLossOrWriteDownMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:UnrealizedLossOrWriteDownMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_InvestmentValuationComponentsAxis_FairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:FairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_InvestmentValuationComponentsAxis_UnrealizedGainMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:UnrealizedGainMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_InvestmentValuationComponentsAxis_UnrealizedLossOrWriteDownMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:UnrealizedLossOrWriteDownMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_ci_InvestmentValuationComponentsAxis_FairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:InvestmentValuationComponentsAxis">ci:FairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FairValueByAssetClassAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FairValueByAssetClassAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_FairValueByAssetClassAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_FairValueByAssetClassAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FairValueByAssetClassAxis_FixedMaturitiesAndEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:FixedMaturitiesAndEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FairValueByAssetClassAxis_GuaranteedMinimumIncomeBenefitsAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ci:GuaranteedMinimumIncomeBenefitsAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_FairValueByLiabilityClassAxis_GuaranteedMinimumIncomeBenefitsNetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ci:GuaranteedMinimumIncomeBenefitsNetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_FinancingReceivableInformationByCreditQualityIndicatorAxis_DebtServiceCoverageRatio130xOrGreaterMember_ci_FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis_LoanToValueRatio100PercentOrAboveMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FinancingReceivableInformationByCreditQualityIndicatorAxis">ci:DebtServiceCoverageRatio130xOrGreaterMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:FinancingReceivableRecordedInvestmentCreditQualityIndicatorRangeAxis">ci:LoanToValueRatio100PercentOrAboveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ci:AccountingStandardsUpdate201026Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumDeathBenefitsMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumDeathBenefitsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumIncomeBenefitsMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumIncomeBenefitsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumDeathBenefitsMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumDeathBenefitsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_DerivativeInstrumentRiskAxis_GuaranteedMinimumIncomeBenefitsMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_OtherRevenueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:GuaranteedMinimumIncomeBenefitsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:OtherRevenueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis">ci:FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedCorporateBondsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ci:FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis">ci:FinancialInstrumentsOwnedCorporateBondsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_EquityAndCurrencyFuturesContractMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:EquityAndCurrencyFuturesContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_DerivativeInstrumentRiskAxis_EquityAndCurrencyFuturesContractMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:EquityAndCurrencyFuturesContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateSwapGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_DerivativeInstrumentRiskAxis_InterestRateSwapGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:InterestRateSwapGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember_us-gaap_DerivativeInstrumentRiskAxis_TreasuryInterestRateFuturesGrowthInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:TreasuryInterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember_us-gaap_DerivativeInstrumentRiskAxis_TreasuryInterestRateFuturesGrowthInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:TreasuryInterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_DerivativeInstrumentRiskAxis_EurodollarInterestRateFuturesGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:EurodollarInterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_DerivativeInstrumentRiskAxis_EurodollarInterestRateFuturesGrowthInterestMember_us-gaap_HedgingDesignationAxis_NondesignatedMember_ci_DerivativesNotDesignatedAsAccountingHedgesAxis_NotionalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ci:EurodollarInterestRateFuturesGrowthInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ci:DerivativesNotDesignatedAsAccountingHedgesAxis">ci:NotionalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue2016275InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2016275InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue2016275InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2016275InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue2021637InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2021637InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue2021637InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue2021637InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Dec31_2011_us-gaap_LongtermDebtTypeAxis_NotesDue20425375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20425375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Mar31_2012_us-gaap_LongtermDebtTypeAxis_NotesDue20425375InterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ci:NotesDue20425375InterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:FirstassistMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:FirstassistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:FirstassistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Nov01_2011_TO_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:FirstassistMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-11-01</xbrli:startDate>
      <xbrli:endDate>2011-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_VestedOptionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis">ci:VestedOptionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_UnvestedOptionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis">ci:UnvestedOptionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_RestrictedStockGrantsAndUnitsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis">ci:RestrictedStockGrantsAndUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012_us-gaap_AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_us-gaap_BusinessAcquisitionAxis_HealthspringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis_OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_BusinessAcquisitionAxis_HealthspringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-01-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_StatementScenarioAxis_SubjectToAppraisalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ci:HealthspringMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">ci:SubjectToAppraisalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementGeographicalAxis_ChinaAndIndonesiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">ci:ChinaAndIndonesiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AS_OF_Jan31_2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000701221</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-01-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="PerShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="Pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <dei:DocumentType id="ID_35751" contextRef="FROM_Jan01_2012_TO_Mar31_2012">10-Q</dei:DocumentType>
  <dei:DocumentPeriodEndDate id="ID_35752" contextRef="FROM_Jan01_2012_TO_Mar31_2012">2012-03-31</dei:DocumentPeriodEndDate>
  <dei:EntityRegistrantName id="ID_35753" contextRef="FROM_Jan01_2012_TO_Mar31_2012">CIGNA Corporation</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="ID_35754" contextRef="FROM_Jan01_2012_TO_Mar31_2012">0000701221</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate id="ID_35755" contextRef="FROM_Jan01_2012_TO_Mar31_2012">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityFilerCategory id="ID_35756" contextRef="FROM_Jan01_2012_TO_Mar31_2012">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:TradingSymbol id="ID_35757" contextRef="FROM_Jan01_2012_TO_Mar31_2012">CI</dei:TradingSymbol>
  <dei:EntityCommonStockSharesOutstanding id="ID_35758_Shares_AsShown" decimals="INF" contextRef="AS_OF_Apr16_2012" unitRef="Shares">288321052</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus id="ID_35759" contextRef="FROM_Jan01_2012_TO_Mar31_2012">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityWellKnownSeasonedIssuer id="ID_35760" contextRef="FROM_Jan01_2012_TO_Mar31_2012">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityVoluntaryFilers id="ID_35761" contextRef="FROM_Jan01_2012_TO_Mar31_2012">No</dei:EntityVoluntaryFilers>
  <dei:EntityPublicFloat id="ID_35762_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">14199000000</dei:EntityPublicFloat>
  <dei:DocumentFiscalYearFocus id="ID_35763" contextRef="FROM_Jan01_2012_TO_Mar31_2012">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="ID_35764" contextRef="FROM_Jan01_2012_TO_Mar31_2012">Q1</dei:DocumentFiscalPeriodFocus>
  <dei:AmendmentFlag id="ID_35944" contextRef="FROM_Jan01_2012_TO_Mar31_2012">false</dei:AmendmentFlag>
  <us-gaap:NetInvestmentIncome id="ID_35765_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">288000000</us-gaap:NetInvestmentIncome>
  <us-gaap:SalesRevenueGoodsNet id="ID_35766_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">386000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:OtherIncome id="ID_35767_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-40000000</us-gaap:OtherIncome>
  <us-gaap:RealizedInvestmentGainsLosses id="ID_35768_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">13000000</us-gaap:RealizedInvestmentGainsLosses>
  <us-gaap:NetInvestmentIncome id="ID_35777_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">279000000</us-gaap:NetInvestmentIncome>
  <us-gaap:SalesRevenueGoodsNet id="ID_35778_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">339000000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:OtherIncome id="ID_35779_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">34000000</us-gaap:OtherIncome>
  <us-gaap:RealizedInvestmentGainsLosses id="ID_35780_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">26000000</us-gaap:RealizedInvestmentGainsLosses>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare id="ID_35781_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">3037000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredOther id="ID_35782_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">1104000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredOther>
  <us-gaap:CostOfGoodsSold id="ID_35783_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">321000000</us-gaap:CostOfGoodsSold>
  <us-gaap:OtherCostAndExpenseOperating id="ID_35784_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">1841000000</us-gaap:OtherCostAndExpenseOperating>
  <us-gaap:BenefitsLossesAndExpenses id="ID_35785_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">6236000000</us-gaap:BenefitsLossesAndExpenses>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare id="ID_35798_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">2077000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredOther id="ID_35799_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">994000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredOther>
  <us-gaap:CostOfGoodsSold id="ID_35800_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">276000000</us-gaap:CostOfGoodsSold>
  <us-gaap:OtherCostAndExpenseOperating id="ID_35801_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">1501000000</us-gaap:OtherCostAndExpenseOperating>
  <us-gaap:BenefitsLossesAndExpenses id="ID_35802_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">4832000000</us-gaap:BenefitsLossesAndExpenses>
  <us-gaap:EarningsPerShareBasic id="ID_35805_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="PerShare">1.30</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted id="ID_35808_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="PerShare">1.28</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareDeclared id="ID_35809_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="PerShare">0.04</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:EarningsPerShareBasic id="ID_35826_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="PerShare">1.53</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted id="ID_35829_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="PerShare">1.51</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareDeclared id="ID_35830_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="PerShare">0.04</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="ID_35831_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">135000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_35832_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">46000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="ID_35839_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">22000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_35840_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">143000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:Revenues id="ID_35941_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">6788000000</us-gaap:Revenues>
  <us-gaap:Revenues id="ID_35942_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">5411000000</us-gaap:Revenues>
  <ci:PremiumsEarnedNetFeesAndCommissions id="ID_35982_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">6141000000</ci:PremiumsEarnedNetFeesAndCommissions>
  <ci:PremiumsEarnedNetFeesAndCommissions id="ID_35983_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">4733000000</ci:PremiumsEarnedNetFeesAndCommissions>
  <ci:OtherRealizedInvestmentGainsLosses id="ID_35984_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">16000000</ci:OtherRealizedInvestmentGainsLosses>
  <ci:OtherRealizedInvestmentGainsLosses id="ID_35985_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">26000000</ci:OtherRealizedInvestmentGainsLosses>
  <ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet id="ID_35986_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-3000000</ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet>
  <ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet id="ID_35987_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">0</ci:OtherThanTemporaryImpairmentsOnDebtSecuritiesNet>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_35988_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-67000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <ci:GuaranteedMinimumIncomeBenefitsExpense id="ID_35989_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-16000000</ci:GuaranteedMinimumIncomeBenefitsExpense>
  <us-gaap:ProfitLoss id="ID_36632_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">371000000</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_36633_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLoss id="ID_36634_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">371000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="ID_36635_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">413000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_36636_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ProfitLoss id="ID_36637_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">414000000</us-gaap:ProfitLoss>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_36638_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">181000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_36639_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">165000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_36640_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">552000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_36641_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">579000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome id="ID_51462_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-8000000</ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome>
  <ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome id="ID_51463_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">2000000</ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ID_51464_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">454000000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest id="ID_51465_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">455000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome id="ID_51466_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">23000000</ci:OtherComprehensiveIncomeFixedMaturitiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ID_51467_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">436000000</us-gaap:ComprehensiveIncomeNetOfTax>
  <ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome id="ID_51468_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">1000000</ci:OtherComprehensiveIncomeEquitySecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseComprehensiveIncome>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest id="ID_51469_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">436000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="ID_36933_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">17049000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="ID_36934_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">16217000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:AvailableForSaleSecuritiesEquitySecurities id="ID_36935_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">107000000</us-gaap:AvailableForSaleSecuritiesEquitySecurities>
  <us-gaap:AvailableForSaleSecuritiesEquitySecurities id="ID_36936_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">100000000</us-gaap:AvailableForSaleSecuritiesEquitySecurities>
  <us-gaap:LoansReceivableCommercialRealEstate id="ID_36937_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">3259000000</us-gaap:LoansReceivableCommercialRealEstate>
  <us-gaap:LoansReceivableCommercialRealEstate id="ID_36938_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">3301000000</us-gaap:LoansReceivableCommercialRealEstate>
  <us-gaap:LoansInsurancePolicy id="ID_36939_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">1488000000</us-gaap:LoansInsurancePolicy>
  <us-gaap:LoansInsurancePolicy id="ID_36940_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1502000000</us-gaap:LoansInsurancePolicy>
  <us-gaap:RealEstateInvestments id="ID_36941_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">79000000</us-gaap:RealEstateInvestments>
  <us-gaap:RealEstateInvestments id="ID_36942_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">87000000</us-gaap:RealEstateInvestments>
  <us-gaap:OtherLongTermInvestments id="ID_36943_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">1095000000</us-gaap:OtherLongTermInvestments>
  <us-gaap:OtherLongTermInvestments id="ID_36944_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1058000000</us-gaap:OtherLongTermInvestments>
  <us-gaap:OtherShortTermInvestments id="ID_36945_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">187000000</us-gaap:OtherShortTermInvestments>
  <us-gaap:OtherShortTermInvestments id="ID_36946_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">225000000</us-gaap:OtherShortTermInvestments>
  <us-gaap:Investments id="ID_36947_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">23264000000</us-gaap:Investments>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_36948_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">2111000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccruedInvestmentIncomeReceivable id="ID_36949_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">291000000</us-gaap:AccruedInvestmentIncomeReceivable>
  <us-gaap:PremiumsAndOtherReceivablesNet id="ID_36950_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">1897000000</us-gaap:PremiumsAndOtherReceivablesNet>
  <us-gaap:ReinsuranceRecoverables id="ID_36951_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">6187000000</us-gaap:ReinsuranceRecoverables>
  <us-gaap:DeferredTaxAssetsNet id="ID_36952_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">533000000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredPolicyAcquisitionCosts id="ID_36953_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">884000000</us-gaap:DeferredPolicyAcquisitionCosts>
  <us-gaap:PropertyPlantAndEquipmentNet id="ID_36954_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">1083000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Goodwill id="ID_36955_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">5726000000</us-gaap:Goodwill>
  <us-gaap:OtherAssets id="ID_36956_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">2328000000</us-gaap:OtherAssets>
  <us-gaap:SeparateAccountAssets id="ID_36957_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">8481000000</us-gaap:SeparateAccountAssets>
  <us-gaap:Assets id="ID_36958_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">52785000000</us-gaap:Assets>
  <us-gaap:Investments id="ID_36959_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">22490000000</us-gaap:Investments>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_36960_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">4690000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccruedInvestmentIncomeReceivable id="ID_36961_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">252000000</us-gaap:AccruedInvestmentIncomeReceivable>
  <us-gaap:PremiumsAndOtherReceivablesNet id="ID_36962_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1358000000</us-gaap:PremiumsAndOtherReceivablesNet>
  <us-gaap:ReinsuranceRecoverables id="ID_36963_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">6256000000</us-gaap:ReinsuranceRecoverables>
  <us-gaap:DeferredPolicyAcquisitionCosts id="ID_36964_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">817000000</us-gaap:DeferredPolicyAcquisitionCosts>
  <us-gaap:PropertyPlantAndEquipmentNet id="ID_36965_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1024000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:DeferredTaxAssetsNet id="ID_36966_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">803000000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:Goodwill id="ID_36967_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">3164000000</us-gaap:Goodwill>
  <us-gaap:OtherAssets id="ID_36968_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1750000000</us-gaap:OtherAssets>
  <us-gaap:SeparateAccountAssets id="ID_36969_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">8093000000</us-gaap:SeparateAccountAssets>
  <us-gaap:Assets id="ID_36970_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">50697000000</us-gaap:Assets>
  <us-gaap:PolicyholderContractDeposits id="ID_36971_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">8566000000</us-gaap:PolicyholderContractDeposits>
  <us-gaap:LiabilityForFuturePolicyBenefits id="ID_36972_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">8404000000</us-gaap:LiabilityForFuturePolicyBenefits>
  <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet id="ID_36973_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">4176000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth id="ID_36974_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">1698000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth>
  <us-gaap:UnearnedPremiums id="ID_36975_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">1050000000</us-gaap:UnearnedPremiums>
  <ci:InsuranceAndContractholderLiabilities id="ID_36976_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">23894000000</ci:InsuranceAndContractholderLiabilities>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent id="ID_36977_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">6632000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:OtherShortTermBorrowings id="ID_36978_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">227000000</us-gaap:OtherShortTermBorrowings>
  <us-gaap:LongTermDebt id="ID_36979_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">4990000000</us-gaap:LongTermDebt>
  <us-gaap:SeparateAccountsLiability id="ID_36981_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">8481000000</us-gaap:SeparateAccountsLiability>
  <us-gaap:Liabilities id="ID_36982_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">44224000000</us-gaap:Liabilities>
  <us-gaap:PolicyholderContractDeposits id="ID_36983_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">8553000000</us-gaap:PolicyholderContractDeposits>
  <us-gaap:LiabilityForFuturePolicyBenefits id="ID_36984_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">8593000000</us-gaap:LiabilityForFuturePolicyBenefits>
  <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet id="ID_36985_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">4146000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth id="ID_36986_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1095000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth>
  <us-gaap:UnearnedPremiums id="ID_36987_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">502000000</us-gaap:UnearnedPremiums>
  <ci:InsuranceAndContractholderLiabilities id="ID_36988_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">22889000000</ci:InsuranceAndContractholderLiabilities>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent id="ID_36989_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">6627000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:OtherShortTermBorrowings id="ID_36990_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">104000000</us-gaap:OtherShortTermBorrowings>
  <us-gaap:LongTermDebt id="ID_36991_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">4990000000</us-gaap:LongTermDebt>
  <us-gaap:SeparateAccountsLiability id="ID_36993_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">8093000000</us-gaap:SeparateAccountsLiability>
  <us-gaap:Liabilities id="ID_36994_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">42703000000</us-gaap:Liabilities>
  <us-gaap:CommonStockValue id="ID_36995_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">92000000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="ID_36996_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">3268000000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax id="ID_36997_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">762000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax id="ID_36998_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">2000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax id="ID_36999_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">-28000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="ID_37000_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">38000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax id="ID_37001_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">1496000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_37002_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">-722000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_37003_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">11123000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:TreasuryStockValue id="ID_37004_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">5200000000</us-gaap:TreasuryStockValue>
  <us-gaap:StockholdersEquity id="ID_37005_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">8561000000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="ID_37008_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">52785000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:CommonStockValue id="ID_37009_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">92000000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="ID_37010_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">3188000000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax id="ID_37011_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">739000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleFixedSecuritiesAdjustmentNetOfTax>
  <ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax id="ID_37012_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1000000</ci:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleEquitySecuritiesAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax id="ID_37013_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">-23000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="ID_37014_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax id="ID_37015_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">1507000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="ID_37016_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">-787000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_37017_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">10787000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:TreasuryStockValue id="ID_37018_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">5286000000</us-gaap:TreasuryStockValue>
  <us-gaap:StockholdersEquity id="ID_37019_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">7994000000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="ID_37022_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">50697000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <ci:ShareholdersEquityPerShare id="ID_37023_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="PerShare">28.00</ci:ShareholdersEquityPerShare>
  <ci:ShareholdersEquityPerShare id="ID_37359_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="PerShare">29.69</ci:ShareholdersEquityPerShare>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="ID_37360_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">15170000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="ID_37361_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">14257000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <ci:AvailableForSaleSecuritiesEquitySecuritiesCost id="ID_37362_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">124000000</ci:AvailableForSaleSecuritiesEquitySecuritiesCost>
  <ci:AvailableForSaleSecuritiesEquitySecuritiesCost id="ID_37363_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">124000000</ci:AvailableForSaleSecuritiesEquitySecuritiesCost>
  <us-gaap:CommonStockParOrStatedValuePerShare id="ID_37364_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="PerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="ID_37365_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="PerShare">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesIssued id="ID_37366_Shares_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="Shares">366000000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="ID_37367_Shares_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="Shares">351000000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesAuthorized id="ID_51471_Shares_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="Shares">600000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50716_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50717_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">3188000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50718_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-787000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50719_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">10787000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50720_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5286000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50721_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">7994000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50722_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">7994000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50723_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">6374000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50724_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50725_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">6356000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50726_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5242000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50727_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">9590000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50728_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-614000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50729_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">2534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50730_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">88000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50731_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">-614000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50732_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ParentMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">6645000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50733_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">9879000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50734_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50735_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_CommonStockMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">88000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50736_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">2534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50737_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50738_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5242000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50739_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementEquityComponentsAxis_ParentMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-289000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50740_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-289000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50741_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">-289000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="ID_50742_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">80000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice id="ID_50743_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">24000000</us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued id="ID_50744_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">86000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_50745_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">65000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:NetIncomeLoss id="ID_50746_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">371000000</us-gaap:NetIncomeLoss>
  <us-gaap:DividendsCommonStockCash id="ID_50747_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:DividendsCommonStockCash id="ID_50748_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:NetIncomeLoss id="ID_50749_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">371000000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50750_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">8561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50751_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50752_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">3268000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50753_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50754_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">11123000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50755_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5200000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50756_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">8561000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50757_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_50758_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice id="ID_51148_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">27000000</us-gaap:TreasuryStockReissuedAtLowerThanRepurchasePrice>
  <us-gaap:MinorityInterestDecreaseFromRedemptions id="ID_51149_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">19000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_51150_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51163_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51166_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011" unitRef="USD">6715000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51167_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">88000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="ID_51168_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">4000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51169_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">2547000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="ID_51170_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">9000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_51171_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51172_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-573000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLoss id="ID_51173_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">413000000</us-gaap:NetIncomeLoss>
  <us-gaap:DividendsCommonStockCash id="ID_51174_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51175_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD">9965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:TreasuryStockValueAcquiredCostMethod id="ID_51176_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">163000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51177_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">-5312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued id="ID_51178_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="USD">93000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="ID_51179_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">4000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_51180_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:NetIncomeLoss id="ID_51181_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">413000000</us-gaap:NetIncomeLoss>
  <us-gaap:DividendsCommonStockCash id="ID_51182_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:TreasuryStockValueAcquiredCostMethod id="ID_51183_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">163000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51184_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">6715000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51298_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">142000000</ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51299_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">142000000</ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_51300_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">65000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_51301_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">65000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:DividendsCommonStockCash id="ID_51302_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">11000000</us-gaap:DividendsCommonStockCash>
  <ci:EffectOfAcquiringNoncontrollingInterestOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51305_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011" unitRef="USD">-15000000</ci:EffectOfAcquiringNoncontrollingInterestOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:DividendsCommonStockCash id="ID_51306_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">11000000</us-gaap:DividendsCommonStockCash>
  <us-gaap:TreasuryStockValueAcquiredCostMethod id="ID_51307_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">163000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease id="ID_51308_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51424_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011_us-gaap_StatementEquityComponentsAxis_ParentMember" unitRef="USD">75000000</ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="ID_51474_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011" unitRef="USD">75000000</ci:EffectOfSharedBasedCompensationStockIssuedOnStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:DepreciationDepletionAndAmortization id="ID_35864_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">126000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="ID_35865_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">83000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:GainLossOnSaleOfInvestments id="ID_35866_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">13000000</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:GainLossOnSaleOfInvestments id="ID_35867_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">26000000</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes id="ID_35868_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-46000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
  <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes id="ID_35869_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-143000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
  <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal id="ID_35870_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">5000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="ID_35871_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">129000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInReinsuranceRecoverable id="ID_35872_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">30000000</us-gaap:IncreaseDecreaseInReinsuranceRecoverable>
  <us-gaap:IncreaseDecreaseInReinsuranceRecoverable id="ID_35873_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">2000000</us-gaap:IncreaseDecreaseInReinsuranceRecoverable>
  <us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts id="ID_35874_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">47000000</us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts>
  <us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts id="ID_35875_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">48000000</us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="ID_35876_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-155000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="ID_35877_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-41000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInInsuranceLiabilities id="ID_35878_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">637000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
  <us-gaap:IncreaseDecreaseInInsuranceLiabilities id="ID_35879_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">77000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="ID_35880_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-166000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="ID_35881_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-366000000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable id="ID_35882_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">105000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable id="ID_35883_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-87000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet id="ID_35884_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">23000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet id="ID_35885_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">44000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="ID_35886_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">941000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="ID_35887_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">51000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt id="ID_35888_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">221000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt id="ID_35889_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">155000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity id="ID_35890_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity id="ID_35891_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
  <us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable id="ID_35892_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">165000000</us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable>
  <us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable id="ID_35893_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">28000000</us-gaap:ProceedsFromSaleAndCollectionOfMortgageNotesReceivable>
  <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments id="ID_35894_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">300000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
  <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments id="ID_35895_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">221000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities id="ID_35896_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">317000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities id="ID_35897_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">319000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
  <us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond id="ID_35898_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">36000000</us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond>
  <us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond id="ID_35899_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">75000000</us-gaap:ProceedsFromRepaymentsOfFirstMortgageBond>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt id="ID_35900_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">831000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt id="ID_35901_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">790000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity id="ID_35902_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity id="ID_35903_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">8000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity>
  <us-gaap:PaymentsToAcquireMortgageNotesReceivable id="ID_35904_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">180000000</us-gaap:PaymentsToAcquireMortgageNotesReceivable>
  <us-gaap:PaymentsToAcquireMortgageNotesReceivable id="ID_35905_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">18000000</us-gaap:PaymentsToAcquireMortgageNotesReceivable>
  <us-gaap:PaymentsToAcquireOtherInvestments id="ID_35906_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">167000000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsToAcquireOtherInvestments id="ID_35907_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">213000000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="ID_35908_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">81000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="ID_35909_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">73000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="ID_35910_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-3419000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="ID_35911_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-316000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:AdditionsToContractHoldersFunds id="ID_35912_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">261000000</us-gaap:AdditionsToContractHoldersFunds>
  <us-gaap:AdditionsToContractHoldersFunds id="ID_35913_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">321000000</us-gaap:AdditionsToContractHoldersFunds>
  <us-gaap:WithdrawalFromContractHoldersFunds id="ID_35914_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">231000000</us-gaap:WithdrawalFromContractHoldersFunds>
  <us-gaap:WithdrawalFromContractHoldersFunds id="ID_35915_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">303000000</us-gaap:WithdrawalFromContractHoldersFunds>
  <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts id="ID_35916_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">22000000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
  <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts id="ID_35917_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">6000000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt id="ID_35918_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">123000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt id="ID_35919_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">-222000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="ID_35920_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="ID_35921_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">591000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:RepaymentsOfLongTermDebt id="ID_35922_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">326000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:RepaymentsOfLongTermDebt id="ID_35923_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">2000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ID_35924_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">45000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ID_35925_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">66000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsOfDividendsCommonStock id="ID_35926_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">0</us-gaap:PaymentsOfDividendsCommonStock>
  <us-gaap:PaymentsOfDividendsCommonStock id="ID_35927_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">0</us-gaap:PaymentsOfDividendsCommonStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="ID_35928_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-106000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="ID_35929_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">305000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="ID_35930_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">5000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="ID_35931_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">11000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="ID_35932_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-2579000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="ID_35933_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">51000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_35934_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1605000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:IncomeTaxesPaidNet id="ID_35935_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">22000000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:IncomeTaxesPaidNet id="ID_35936_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">106000000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:InterestPaid id="ID_35937_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">54000000</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="ID_35938_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">27000000</us-gaap:InterestPaid>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="ID_35945_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2011" unitRef="USD">1656000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal id="ID_35950_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">5000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables id="ID_35951_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">215000000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:PaymentsForRepurchaseOfCommonStock id="ID_36653_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsForRepurchaseOfCommonStock id="ID_36654_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">152000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="ID_36844_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">3199000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="ID_36845_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">12000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="ID_35841" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;B&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;asis of Presentation&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;igna&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Corporation is a holding company and is not an insurance company.  Its subsidiaries conduct various businesses, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; are described in its &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Annual Report on Form 10-K for the year ended December 31, 2011 (&amp;#8220;201&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Form 10-K&amp;#8221;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;   As used in this document, &amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;igna&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221; or &amp;#8220;the Company&amp;#8221; may refer to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;igna&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Corporation itself, one or more of its subsidiaries, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;igna&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Corporation and its consolidated subsidiaries.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Consolidated Financial S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements include the accounts of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;igna&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Corporatio&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;n and its significant subsidiaries&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Intercompany transactions and accounts have been eliminated in consolidation&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;These Consolidated Financial S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements were prepared in conformity with accounting principles generally accepted in the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;United States of America&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GAAP&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;).&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company is a global health services organization with insurance subsidiaries that are major providers of medical, dental, disability, life and accident insurance and related products and services. In&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;U.S.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, the majority of these products and services are offered through employers and other groups (e.g. unions and associations) and, in selected international markets, Cigna offers supplemental&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;health, life and accident insurance products and international health care coverage and services to businesses, governmental and non&lt;/font&gt;&lt;font style="font-family:Cambria;font-size:10pt;"&gt;&amp;#8208;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;governmental organizations and individuals. In addition to its&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ongoing operations described above, the Company also has certain run&lt;/font&gt;&lt;font style="font-family:Cambria;font-size:10pt;"&gt;&amp;#8208;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;off operations, including a Run&lt;/font&gt;&lt;font style="font-family:Cambria;font-size:10pt;"&gt;&amp;#8208;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;off Reinsurance segment.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The interim consolidated financial statements are unaudited but include all adjustments (including normal recurring adjustments) necessary, in the opinion of management, for a fair statement of financial position and results of operations for the periods reported.  The interim consolidated financial statements and notes should be read in conjunction with the Consolidated Financial Statements and Notes in the Company's &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;201&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Form 10-K&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The preparation of interim consolidated financial statements necessarily relies heavily on estimates.  This and certain other factors, such as the seasonal nature of portions of the health care and related benefits business as well as competitive and other market conditions, call for caution in estimating full year results based on interim results of operations.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Certain &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;reclassifications&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;have been made to prior period amounts to conform to the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; current presentation.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;As explained further in Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;on&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; January &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1, 2012, the Company a&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;cquired HealthSpring, Inc.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;approximately &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$3.8 billion.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:NetIncomeLoss id="ID_51147_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-67000000</us-gaap:NetIncomeLoss>
  <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock id="ID_36926" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Note 2&lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;font-weight:bold;"&gt; &amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Recent Accounting Pronouncements &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;margin-left:-18px;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;Deferred &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;policy &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;acquisition c&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;osts.&lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2012&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company adopted &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Financial Accounting Standards Board&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;'s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&amp;#8220;FASB&amp;#8221;) amended guidance (ASU 2010-26)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; on&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; accounting &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; costs to acqui&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;re&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; or renew insurance contracts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;This guidance&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; require&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;certain &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;sales compensation and telemarketing &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;costs related to unsuccessful efforts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and any indirect costs&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;to be expensed as incurred. The Company's deferred acquisition costs arise from sales and renewal activities primarily in its International segment&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.   &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;This &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;amended&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; guidance &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;was implemented&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; through retrospective adjustment of comparative prior periods.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;As reported in the Consolidated Statement of Equity, the cumulative effect of adopting the amended accounting guidance as of January 1, 2011 was a reduction in Total Shareholders' Equity of $289 million.  Full-year 2011 shareholders' net income on a retrospectively adjusted basis was reduced by $67 million&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, partially offset by increased foreign currency translation of $6 million, resulting in a cumulative impact on Total Shareholders' Equity as of December 31, 2011 of $350 million.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Summarized below are the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;effects&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;amended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;guidance on previously reported amounts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for the three months ended March 31, 201&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Condensed Consolidated Statement of Income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Three Months Ended March 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Revenues, excluding other revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,377&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,377&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (2)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 34&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total Revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,413&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (2)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,411&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Benefits and expenses, excluding other operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,331&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3,331&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,482&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,501&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total benefits and expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 4,813&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 4,832&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Income before Income Taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 600&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (21)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 579&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Current income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 22&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 22&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 148&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (5)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (5)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 165&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 430&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 414&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Net income attributable to Noncontrolling Interest&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' Net Income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 429&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 413&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 8px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Earnings per share:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Basic&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.59&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (0.06)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.53&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Diluted&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.57&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (0.06)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.51&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Condensed Consolidated Balance sheet&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;As of December 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred policy acquisition costs&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,312&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (495)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 817&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 632&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 171&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 803&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other assets, including other intangibles&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,776&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (26)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,750&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;All other assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 47,327&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 47,327&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 51,047&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (350)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 50,697&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 9px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net translation of foreign currencies&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (3)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Retained earnings&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 11,143&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (356)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 10,787&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other shareholders' equity&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (2,796)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (2,796)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shareholders' equity&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 8,344&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (350)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 7,994&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Condensed Consolidated Statement of Cash Flows&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Three Months Ended March 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 430&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 414&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 148&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (5)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred policy acquisition expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (67)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (48)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 39&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 2&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 41&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Note 16&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Segment information:   International&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Three Months Ended March 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 8px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums and fees and other revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 706&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (2)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 704&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Segment earnings&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 77&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 61&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Presentation of Comprehensive Income.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2012, the Company adopted the FASB's amended guidance (ASU 2011-05) that requires presenting net income and other comprehensive income in either a single continuous statement or in two separate, but consecutive statements. Neither measurement of comprehensive income nor disclosure requirements for reclassification adjustments between other comprehensive income and net income were affected by this&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; amended&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; guidance.  The Company has elected to present a separate statement of comprehensive income following the statement of income and has retrospectively adjusted prior periods to conform to the new presentation, as required.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Amendments to Fair Value Measurement and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;Disclosure&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2012, the Company adopted the FASB's amended guidance on fair value measurement and disclosure (ASU 2011-04) on a prospective basis.  A key objective was to achieve common fair value measurement and disclosure requirements between U.S. GAAP and IFRS.  The amended guidance changes certain fair value measurement principles and expands required disclosures to include quantitative and qualitative information about unobservable inputs in Level 3 measurements and leveling for financial instruments not carried at fair value in the financial statements.  Upon adoption, there were no effects on the Company's fair value measurements.  See Note 7 for expanded fair value disclosures. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
  <ci:DeferredAcquisitionCostsPolicy id="ID_37489" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:-18px;"&gt;Deferred &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;policy &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;acquisition c&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;osts.&lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2012&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company adopted &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Financial Accounting Standards Board&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;'s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&amp;#8220;FASB&amp;#8221;) amended guidance (ASU 2010-26)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; on&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; accounting &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; costs to acqui&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;re&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; or renew insurance contracts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;This guidance&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; require&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;certain &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;sales compensation and telemarketing &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;costs related to unsuccessful efforts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and any indirect costs&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;to be expensed as incurred. The Company's deferred acquisition costs arise from sales and renewal activities primarily in its International segment&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.   &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;This &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;amended&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; guidance &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;was implemented&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; through retrospective adjustment of comparative prior periods.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;As reported in the Consolidated Statement of Equity, the cumulative effect of adopting the amended accounting guidance as of January 1, 2011 was a reduction in Total Shareholders' Equity of $289 million.  Full-year 2011 shareholders' net income on a retrospectively adjusted basis was reduced by $67 million&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, partially offset by increased foreign currency translation of $6 million, resulting in a cumulative impact on Total Shareholders' Equity as of December 31, 2011 of $350 million.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Summarized below are the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;effects&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;amended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;guidance on previously reported amounts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for the three months ended March 31, 201&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:DeferredAcquisitionCostsPolicy>
  <ci:BenefitsAndExpensesExcludingOtherOperatingExpenses id="ID_50845_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">3331000000</ci:BenefitsAndExpensesExcludingOtherOperatingExpenses>
  <us-gaap:BenefitsLossesAndExpenses id="ID_50846_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">4813000000</us-gaap:BenefitsLossesAndExpenses>
  <us-gaap:OtherCostAndExpenseOperating id="ID_50847_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">1482000000</us-gaap:OtherCostAndExpenseOperating>
  <us-gaap:OtherIncome id="ID_50848_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">36000000</us-gaap:OtherIncome>
  <us-gaap:Revenues id="ID_50849_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">5413000000</us-gaap:Revenues>
  <ci:RevenuesExcludingOtherRevenues id="ID_50850_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">5377000000</ci:RevenuesExcludingOtherRevenues>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="ID_50851_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">22000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_50852_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">148000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_50853_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">170000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLoss id="ID_50854_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">429000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_50855_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ProfitLoss id="ID_50856_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">430000000</us-gaap:ProfitLoss>
  <us-gaap:EarningsPerShareBasic id="ID_50857_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="PerShare">1.59</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted id="ID_50858_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="PerShare">1.57</us-gaap:EarningsPerShareDiluted>
  <ci:BenefitsAndExpensesExcludingOtherOperatingExpenses id="ID_50859_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">0</ci:BenefitsAndExpensesExcludingOtherOperatingExpenses>
  <us-gaap:BenefitsLossesAndExpenses id="ID_50860_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">19000000</us-gaap:BenefitsLossesAndExpenses>
  <us-gaap:CurrentIncomeTaxExpenseBenefit id="ID_50861_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="ID_50862_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-5000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="ID_50863_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-5000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:OtherCostAndExpenseOperating id="ID_50864_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">19000000</us-gaap:OtherCostAndExpenseOperating>
  <us-gaap:OtherIncome id="ID_50865_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-2000000</us-gaap:OtherIncome>
  <us-gaap:Revenues id="ID_50866_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-2000000</us-gaap:Revenues>
  <ci:RevenuesExcludingOtherRevenues id="ID_50867_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">0</ci:RevenuesExcludingOtherRevenues>
  <us-gaap:ProfitLoss id="ID_50868_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-16000000</us-gaap:ProfitLoss>
  <us-gaap:EarningsPerShareBasic id="ID_50869_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="PerShare">-0.06</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted id="ID_50870_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="PerShare">-0.06</us-gaap:EarningsPerShareDiluted>
  <us-gaap:NetIncomeLoss id="ID_50874_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-16000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="ID_50878_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="ID_50951_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <ci:AllOtherAssets id="ID_50952_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">47327000000</ci:AllOtherAssets>
  <us-gaap:Assets id="ID_50953_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">51047000000</us-gaap:Assets>
  <us-gaap:DeferredPolicyAcquisitionCosts id="ID_50954_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">1312000000</us-gaap:DeferredPolicyAcquisitionCosts>
  <us-gaap:DeferredTaxAssetsNet id="ID_50955_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">632000000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:OtherAssets id="ID_50956_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">1776000000</us-gaap:OtherAssets>
  <ci:OtherShareholdersEquity id="ID_50957_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">-2796000000</ci:OtherShareholdersEquity>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_50958_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">11143000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="ID_50959_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">8344000000</us-gaap:StockholdersEquity>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="ID_50960_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">6000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <ci:AllOtherAssets id="ID_50961_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">0</ci:AllOtherAssets>
  <us-gaap:Assets id="ID_50962_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-350000000</us-gaap:Assets>
  <us-gaap:DeferredPolicyAcquisitionCosts id="ID_50963_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-495000000</us-gaap:DeferredPolicyAcquisitionCosts>
  <us-gaap:DeferredTaxAssetsNet id="ID_50964_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">171000000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:OtherAssets id="ID_50965_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-26000000</us-gaap:OtherAssets>
  <ci:OtherShareholdersEquity id="ID_50966_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">0</ci:OtherShareholdersEquity>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="ID_50967_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-356000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="ID_50968_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-350000000</us-gaap:StockholdersEquity>
  <ci:RevenuesExcludingOtherRevenues id="ID_51229_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">5377000000</ci:RevenuesExcludingOtherRevenues>
  <ci:BenefitsAndExpensesExcludingOtherOperatingExpenses id="ID_51230_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">3331000000</ci:BenefitsAndExpensesExcludingOtherOperatingExpenses>
  <ci:OtherShareholdersEquity id="ID_51231_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">-2796000000</ci:OtherShareholdersEquity>
  <ci:AllOtherAssets id="ID_51232_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">47327000000</ci:AllOtherAssets>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_51258_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">600000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="ID_51259_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-21000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <ci:EffectOfAdoptionOfAccountingStandardsUpdate201026 id="ID_51309" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Condensed Consolidated Statement of Income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Three Months Ended March 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Revenues, excluding other revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,377&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,377&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 36&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (2)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 34&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total Revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,413&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (2)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 5,411&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Benefits and expenses, excluding other operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,331&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3,331&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,482&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,501&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total benefits and expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 4,813&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 4,832&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Income before Income Taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 600&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (21)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 579&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Current income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 22&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 22&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 148&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (5)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (5)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 165&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 430&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 414&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Net income attributable to Noncontrolling Interest&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' Net Income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 429&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 413&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 8px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Earnings per share:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Basic&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.59&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (0.06)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.53&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Diluted&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.57&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (0.06)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.51&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Condensed Consolidated Balance sheet&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;As of December 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred policy acquisition costs&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,312&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (495)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 817&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 632&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 171&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 803&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other assets, including other intangibles&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,776&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (26)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,750&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;All other assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 47,327&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 47,327&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 51,047&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (350)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 50,697&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 9px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:73px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net translation of foreign currencies&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (3)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Retained earnings&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 11,143&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (356)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 10,787&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 383px; text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other shareholders' equity&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 73px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (2,796)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (2,796)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 383px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:383px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total shareholders' equity&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 73px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:73px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 8,344&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (350)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 7,994&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Condensed Consolidated Statement of Cash Flows&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Three Months Ended March 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 430&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 414&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 148&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (5)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred policy acquisition expenses&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (67)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (48)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 39&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 2&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 41&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Note 16&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Segment information:   International&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Three Months Ended March 31, 2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:2px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;amended &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;As previously&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;accounting&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;retrospectively&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;guidance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;adjusted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 8px"&gt;&lt;td   style="width: 376px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:81px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:80px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:94px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums and fees and other revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 81px; text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 706&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 80px; text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (2)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 94px; text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 704&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 376px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:376px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Segment earnings&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 81px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:81px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 77&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 80px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:80px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (16)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 61&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:EffectOfAdoptionOfAccountingStandardsUpdate201026>
  <ci:NonInvestmentRevenue id="ID_50935_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">706000000</ci:NonInvestmentRevenue>
  <ci:TotalSegmentEarnings id="ID_50936_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">77000000</ci:TotalSegmentEarnings>
  <ci:NonInvestmentRevenue id="ID_50937_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-2000000</ci:NonInvestmentRevenue>
  <ci:TotalSegmentEarnings id="ID_50938_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_ci_SegmentReportingReconcilingItemsforRevenueAndOperatingProfitLossFromSegmentsToConsolidatedAxis_InternationalSegmentMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-16000000</ci:TotalSegmentEarnings>
  <us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts id="ID_50939_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">67000000</us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="ID_50940_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">-39000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts id="ID_50942_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-19000000</us-gaap:IncreaseDecreaseInDeferredPolicyAcquisitionCosts>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="ID_50943_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-2000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes id="ID_51233_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">-148000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
  <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes id="ID_51234_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201026Member_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">5000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
  <ci:FairValueOfFinancialInstrumentsPolicyTextBlock id="ID_51459" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Amendments to Fair Value Measurement and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;Disclosure&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2012, the Company adopted the FASB's amended guidance on fair value measurement and disclosure (ASU 2011-04) on a prospective basis.  A key objective was to achieve common fair value measurement and disclosure requirements between U.S. GAAP and IFRS.  The amended guidance changes certain fair value measurement principles and expands required disclosures to include quantitative and qualitative information about unobservable inputs in Level 3 measurements and leveling for financial instruments not carried at fair value in the financial statements.  Upon adoption, there were no effects on the Company's fair value measurements.  See Note 7 for expanded fair value disclosures. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:FairValueOfFinancialInstrumentsPolicyTextBlock>
  <ci:PresentationOfComprehensiveIncome id="ID_51460" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Presentation of Comprehensive Income.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Effective January 1, 2012, the Company adopted the FASB's amended guidance (ASU 2011-05) that requires presenting net income and other comprehensive income in either a single continuous statement or in two separate, but consecutive statements. Neither measurement of comprehensive income nor disclosure requirements for reclassification adjustments between other comprehensive income and net income were affected by this&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; amended&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; guidance.  The Company has elected to present a separate statement of comprehensive income following the statement of income and has retrospectively adjusted prior periods to conform to the new presentation, as required.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:PresentationOfComprehensiveIncome>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock id="ID_51347" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note 3 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Acquisitions&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company may from time to time acquire or dispose of assets, subsidiaries or lines of business.  Significant transactions are described below.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:18px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Acquisition of HealthSpring, Inc.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;On January 31, 2012 the Company acquired &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;t&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he outstanding shares of HealthSpring, Inc. (&amp;#8220;HealthSpring&amp;#8221;) for $55 per share in cash and Cigna stock awards, representing a cost of approximately $3.8 billion.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;HealthSpring provides Medicare Advantage coverage in 11 states and the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;District of Columbia&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, as well as a large, national stand-alone Medicare prescription drug business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The acquisition of HealthSpring strengthens the Company's ability to serve individuals across their life stages as well as deepens its presence in a number of geographic markets. The addition of HealthSpring brings industry leading physician partnership capabilities and creates the opportunity to deepen the Company's existing client and customer relationships, as well as facilitates a broader deployment of its range of health and wellness capabilities and product offerings.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company funded the acquisition with internal cash resources&lt;/font&gt;&lt;font style="font-family:Stone Serif;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:0px;"&gt;Merger consideration&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;:  The estimated merger consideration of $3.8 billion &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;was calculated&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;HealthSpring, Inc. common shares outstanding at January 30, 2011&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (1)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 67.8&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: common shares outstanding not settled in cash&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (0.1)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common shares settled in cash&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 67.7&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Price per share&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 55&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Cash consideration for outstanding shares&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (1)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3,726&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Fair value of share-based compensation awards&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 65&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Additional cash and equity consideration&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 21&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total merger consideration&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3,812&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 10px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(1) Includes 922,000 shares subject to appraisal that the Company has accrued for at $55 per share.&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Fair value of share-based compensation awards.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;On t&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he date of the acquisition&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; HealthSpring employees' awards of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; options and restricted &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shares&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of HealthSpring stock &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;were rolled over to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Cigna stock opt&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ions and restricted stock&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Each holder of a HealthSpring stock option or restricted stock award received 1.24&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Cigna stock opt&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ions &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;or&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; restricted stock&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;awards. The &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;conversion ratio of 1.24 at the date of acquisition&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; was&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;determined&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; by dividing the acquisition price of HealthSpring shares of $55 by the price of Cigna stock on January 31, 2012 of $44.43&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he Cigna &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;stock option &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;exercise price was determined by&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;using this same&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; conversion ratio&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;V&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;esting periods and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;remaining life of the options &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;rolled&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; over &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;with &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the original HealthSpring awards.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Using fair value as of the acquisition date, the Company valued &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;restricted stock at Cigna's stock price and stock option&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; using a Black-Scholes pricing model. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The assumptions used were generally consistent with those disclosed in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Note 2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Company's 2011 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Consolidat&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ed Financial S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;tatements included in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Form 10-K, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;except &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the expected life assumption of these options ranged from 1.8 to 4.8 years&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and the exercise price did not equal the market value at the grant date&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Because&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the exercise price at the acquisition date&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; f&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;or&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; substantially all of the options was &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;significantly &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;below Cigna's stock price, fair value of the new stock options approximated intrinsic value&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The fair value of the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;se&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;option&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and restricted stock&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;included in&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the purchase price &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;to the extent that services &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;had&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; been &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;pro&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;vided prior to the acquisition&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; based on the grant date &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;original &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;HealthSpring award &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and vesting period.   The remaining fair value not included in the purchase price will be recorded as &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;compensation &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;expense in future periods&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; over the remaining vesting period&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;M&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ost &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of the expense is expected to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;be recognized in 2012 and 2013.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The following table summarizes the effect of the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;se&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;rollover&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; awards &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; former&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; HealthSpring employees.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:left;border-color:#000000;min-width:68px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 31px; text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:left;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:left;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:left;border-color:#000000;min-width:49px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 17px; text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:left;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:left;border-color:#000000;min-width:56px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Compensation &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 31px; text-align:center;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:center;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;exercise/&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:center;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:center;border-color:#000000;min-width:49px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 17px; text-align:center;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:center;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:center;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Included&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:center;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:center;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;expense &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Number of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; text-align:center;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:center;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;award&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:center;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:center;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Fair value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; text-align:center;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:center;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:center;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;in purchase&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:center;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:center;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;post-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(awards in thousands, dollars in millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;awards&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;price&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;of awards&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;price&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;acquisition&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Vested options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 589&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:16px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 54px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14.04&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:7px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 49px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 18&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:14px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 56px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 18&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Unvested options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,336&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:left;border-color:#000000;min-width:16px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 54px; text-align:right;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 16.21&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:left;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:left;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:left;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 28&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Restricted stock&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 786&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:16px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 54px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44.43&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 35&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 16&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 307px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 2,711&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:54px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 22px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:7px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 49px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 90&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:14px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 56px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 65&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 25&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Purchase price allocation&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;In accordance with GAAP, the total purchase price has been allocated to the tangible and intangible net assets acquired based on management's preliminary estimates of their fair values and may change as additional information becomes available over the next several months. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Goodwill&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is allocated to the Health Care segment&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;has not yet been allocated to a reporting unit as of March 31, 2012 and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is not deductible for federal income tax purposes. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;During the three months ended March 31, 2012, the Company recorded $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;41&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;pre&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;-tax ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;28&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;after&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;-tax) of acquisition-related costs in other operating expenses.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The condensed balance sheet of HealthSpring at the acquisition date was as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Investments&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 612&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 492&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums, accounts and notes receivable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 320&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,547&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 795&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 94&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4,860&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Insurance liabilities&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 514&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 208&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Debt&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 326&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total liabilities acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,048&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,812&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In accordance with debt covenants, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;HealthSpring's debt &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;obligation was &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;paid &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;immediately following the acquisition&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.  Th&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; repayment is reported &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;as a &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;financing activity in the statement of cash flows for the three months ended March 31, 2012.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;estimated &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;fair values and useful lives for all intangible assets are as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 30px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(Dollars in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Estimated Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:102px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Estimated Useful Life (In Years)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Customer relationships&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;711&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:102px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;84&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:102px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;3-10&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total other intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;795&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:102px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The fair value of the customer relationship and the amortization method were determined using an income approach that relies on projected future net cash flows including key assumptions for the customer attrition rate and discount rate.  The estimated weighted average useful life reflects the time period&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and pattern of use that &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Cigna &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;expects for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;over 90% of the projected benefits.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Accordingly&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, amortization will be recorded on an accelerated basis in 2012 and decline in subsequent years.   &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The results&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of HealthSpring have been included in the Company's Consolidated Financial Statements from the date of the acquisition.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Revenues of HealthSpring included in the Company's results for three months ended March 31, 2012 were approximately $1.0 billion.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  Net income for HealthSpring was &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;determined to be immaterial.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;"&gt;Pro forma information.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The following table presents selected unaudited pro forma information for the Company assuming the acquisition of HealthSpring had occurred as of January 1, 2011.  This pro forma information does not purport to represent what the Company's actual results would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 23px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 192px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:192px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Unaudited&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 23px; text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 192px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:192px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 7,277&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6,812&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' net income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 381&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 427&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Earnings per share:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 24px; text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Basic&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.33&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.49&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Diluted&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.32&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.46&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:36px;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;text-decoration:underline;"&gt;Acquisition of FirstAssist&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In November 2011, the Company acquired FirstAssist Group Holdings Limited (&amp;#8220;FirstAssist&amp;#8221;) for approximately $115 million,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;using available cash on hand.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;FirstAssist is based in the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;United Kingdom&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and provides travel and protection insurance services &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company expects will enhance its individual business in the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;U.K.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and around the world. &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In accordance with GAAP, the total purchase price has been allocated to the tangible and intangible net assets acquired based on management's preliminary estimates of their fair values and may change as additional information becomes available over the next several months. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;During the first quarter of 2012, the Company updated its allocation of the purchase price based on additional information.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Accordingly, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;allocat&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ion&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to intangible assets&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; was decreased by $18 million from $58 million reported at &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2011 to $40 million. The allocation to goodwill was increased by &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$7 million from &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$56 million &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;reported at December 31, 2011 to $63 million.  G&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;oodwill is reported in the International segment.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The results of FirstAssist are included in the Company's Consolidated Financial Statements from the date of acquisition.  The pro forma effect&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; assuming the acquisition had occurred as of January 1, 2010 were not material to the Company's total revenues&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; shareholders' net income &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and earnings per share &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for the three months ended March  31, 2011.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
  <ci:BusinessAcquisitionDescriptionOfAcquiredEntityTextBlock id="ID_51349" contextRef="FROM_Jan01_2012_TO_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">HealthSpring provides Medicare Advantage coverage in 11 states and the District of Columbia, as well as a large, national stand-alone Medicare prescription drug business.</ci:BusinessAcquisitionDescriptionOfAcquiredEntityTextBlock>
  <ci:BusinessCombinationReasonForBusinessCombinationTextBlock id="ID_51350" contextRef="FROM_Jan01_2012_TO_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">.  The acquisition of HealthSpring strengthens the Company&amp;#8217;s ability to serve individuals across their life stages as well as deepens its presence in a number of geographic markets. The addition of HealthSpring brings industry leading physician partnership capabilities and creates the opportunity to deepen the Company&amp;#8217;s existing client and customer relationships, as well as facilitates a broader deployment of its range of health and wellness capabilities and product offerings.</ci:BusinessCombinationReasonForBusinessCombinationTextBlock>
  <ci:BusinessAcquisitionEffectiveDateOfAcquisitionTextBlock id="ID_51312" contextRef="FROM_Jan01_2012_TO_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">January 31, 2012</ci:BusinessAcquisitionEffectiveDateOfAcquisitionTextBlock>
  <ci:BusinessAcquisitionAcquisitionCostsAfterTax id="ID_51315_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">28000000</ci:BusinessAcquisitionAcquisitionCostsAfterTax>
  <ci:BusinessAcquisitionNameOfAcquiredEntityTextBlock id="ID_51316" contextRef="FROM_Jan01_2012_TO_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">HealthSpring, Inc.</ci:BusinessAcquisitionNameOfAcquiredEntityTextBlock>
  <ci:BusinessAcquisitionAcquisitionCostsPretax id="ID_51318_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">41000000</ci:BusinessAcquisitionAcquisitionCostsPretax>
  <ci:ConversionRatioHealthSpringToCignaStock id="ID_51331_Pure_2Decimal" decimals="2" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="Pure">1.24</ci:ConversionRatioHealthSpringToCignaStock>
  <ci:SharePrice id="ID_51332_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="PerShare">44.43</ci:SharePrice>
  <ci:BusinessCombinationGoodwillRecognizedSegmentAllocationTextBlock id="ID_51333" contextRef="FROM_Jan01_2012_TO_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember">Health Care segment</ci:BusinessCombinationGoodwillRecognizedSegmentAllocationTextBlock>
  <us-gaap:Revenues id="ID_51334_USD_InBillions1Decimal" decimals="-8" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">1000000000</us-gaap:Revenues>
  <ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill id="ID_51335_USD_InMillions" decimals="-6" contextRef="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember" unitRef="USD">40000000</ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount id="ID_51336_USD_InMillions" decimals="-6" contextRef="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">56000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount id="ID_51337_USD_InMillions" decimals="-6" contextRef="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">7000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount id="ID_51338_USD_InMillions" decimals="-6" contextRef="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember" unitRef="USD">63000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill id="ID_51339_USD_InMillions" decimals="-6" contextRef="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember_us-gaap_StatementScenarioAxis_ScenarioPreviouslyReportedMember" unitRef="USD">58000000</ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
  <ci:BusinessAcquisitionEffectiveDateOfAcquisitionTextBlock id="ID_51340" contextRef="FROM_Nov01_2011_TO_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember">November 2011</ci:BusinessAcquisitionEffectiveDateOfAcquisitionTextBlock>
  <ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill id="ID_51341_USD_InMillions" decimals="-6" contextRef="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember_us-gaap_StatementScenarioAxis_RestatementAdjustmentMember" unitRef="USD">-18000000</ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice id="ID_51342_USD_InMillions" decimals="-6" contextRef="AS_OF_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember" unitRef="USD">115000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
  <ci:BusinessAcquisitionNameOfAcquiredEntityTextBlock id="ID_51343" contextRef="FROM_Nov01_2011_TO_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember">FirstAssist Group Holdings Limited</ci:BusinessAcquisitionNameOfAcquiredEntityTextBlock>
  <ci:BusinessCombinationGoodwillRecognizedSegmentAllocationTextBlock id="ID_51344" contextRef="FROM_Nov01_2011_TO_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember">International segment</ci:BusinessCombinationGoodwillRecognizedSegmentAllocationTextBlock>
  <us-gaap:CommonStockSharesOutstanding id="ID_51426_Shares_AsShown" decimals="INF" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_StatementScenarioAxis_SubjectToAppraisalMember" unitRef="Shares">922000</us-gaap:CommonStockSharesOutstanding>
  <ci:BusinessAcquisitionShareBasedCompensationExpectedOptionLifeLow id="ID_51427_Pure_AsShownDecimals1" decimals="1" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="Pure">1.8</ci:BusinessAcquisitionShareBasedCompensationExpectedOptionLifeLow>
  <ci:BusinessAcquisitionShareBasedCompensationExpectedOptionLifeHigh id="ID_51428_Pure_AsShownDecimals1" decimals="1" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="Pure">4.8</ci:BusinessAcquisitionShareBasedCompensationExpectedOptionLifeHigh>
  <ci:AcquiredFiniteLivedIntangibleAssetsPercentOfProjectBenefitsReflectedInWeightedAverageUsefulLifeAssumptions id="ID_51473_Pure_2Decimal" decimals="2" contextRef="AS_OF_Jan31_2012" unitRef="Pure">0.9</ci:AcquiredFiniteLivedIntangibleAssetsPercentOfProjectBenefitsReflectedInWeightedAverageUsefulLifeAssumptions>
  <us-gaap:CommonStockSharesOutstanding id="ID_51319_Shares_InMillions1Decimal" decimals="-5" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="Shares">67800000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable id="ID_51320_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">65000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable>
  <ci:BusinessAcquisitionCostOfAcquiredEntityCommonSharesSettledInCash id="ID_51321_Shares_InMillions1Decimal" decimals="-5" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="Shares">67700000</ci:BusinessAcquisitionCostOfAcquiredEntityCommonSharesSettledInCash>
  <ci:BusinessAcquisitionCostOfAcquiredEntityPricePaidPerShare id="ID_51322_PerShare_AsShown" decimals="INF" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="PerShare">55</ci:BusinessAcquisitionCostOfAcquiredEntityPricePaidPerShare>
  <ci:BusinessAcquisitionCostOfAcquiredEntityAdditionalCashAndEquityConsideration id="ID_51323_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">21000000</ci:BusinessAcquisitionCostOfAcquiredEntityAdditionalCashAndEquityConsideration>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice id="ID_51324_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">3812000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
  <ci:BusinessAcquisitionCostOfAcquiredEntityCommonSharesNotSettledInCash id="ID_51325_Shares_InMillions1Decimal" decimals="-5" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="Shares">100000</ci:BusinessAcquisitionCostOfAcquiredEntityCommonSharesNotSettledInCash>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid id="ID_51326_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">3726000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityCashPaid>
  <ci:CalculationOfEstimatedMergerConsiderationHeathspring id="ID_51346" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;HealthSpring, Inc. common shares outstanding at January 30, 2011&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (1)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 67.8&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: common shares outstanding not settled in cash&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (0.1)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Common shares settled in cash&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 67.7&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Price per share&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 55&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Cash consideration for outstanding shares&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; (1)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3,726&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Fair value of share-based compensation awards&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 65&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Additional cash and equity consideration&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 21&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total merger consideration&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 3,812&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 10px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:2px;text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(1) Includes 922,000 shares subject to appraisal that the Company has accrued for at $55 per share.&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:CalculationOfEstimatedMergerConsiderationHeathspring>
  <ci:RolloverAwardsForHealthspringEmployees id="ID_51356" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:left;border-color:#000000;min-width:68px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 31px; text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:left;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:left;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:left;border-color:#000000;min-width:49px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 17px; text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:left;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:left;border-color:#000000;min-width:56px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Compensation &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 31px; text-align:center;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:center;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;exercise/&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:center;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:center;border-color:#000000;min-width:49px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 17px; text-align:center;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:center;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:center;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Included&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:center;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:center;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;expense &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Number of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; text-align:center;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:center;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;award&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:center;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:center;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Fair value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; text-align:center;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:center;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:center;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;in purchase&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:center;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:center;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;post-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(awards in thousands, dollars in millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;awards&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;price&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;of awards&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;price&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;acquisition&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Vested options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 589&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:16px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 54px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14.04&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:7px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 49px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 18&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:14px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 56px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 18&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Unvested options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1,336&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; text-align:left;border-color:#000000;min-width:16px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 54px; text-align:right;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 16.21&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; text-align:left;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; text-align:left;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; text-align:left;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 28&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 307px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Restricted stock&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 786&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:16px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 54px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:54px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 44.43&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 22px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:7px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 49px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 35&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:14px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 56px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 19&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 68px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 16&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 307px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:307px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 2,711&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 31px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:31px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 16px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 54px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:54px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 22px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:22px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 7px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:7px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 49px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:49px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 90&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 17px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:17px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 14px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:14px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 56px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:56px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 65&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 68px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:68px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 25&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:RolloverAwardsForHealthspringEmployees>
  <ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards id="ID_51357_Shares_InThousands" decimals="-3" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="Shares">2711000</ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice id="ID_51358_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">65000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice>
  <ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense id="ID_51359_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">25000000</ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense>
  <ci:BusinessAcquisitionShareBasedCompensationAverageExerciseAwardPrice id="ID_51360_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_VestedOptionsMember" unitRef="PerShare">14.04</ci:BusinessAcquisitionShareBasedCompensationAverageExerciseAwardPrice>
  <ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards id="ID_51361_Shares_InThousands" decimals="-3" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_VestedOptionsMember" unitRef="Shares">589000</ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards>
  <ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense id="ID_51362_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_VestedOptionsMember" unitRef="USD">0</ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice id="ID_51363_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_VestedOptionsMember" unitRef="USD">18000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards id="ID_51364_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_VestedOptionsMember" unitRef="USD">18000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards id="ID_51365_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">90000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards id="ID_51366_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_UnvestedOptionsMember" unitRef="USD">37000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards>
  <ci:BusinessAcquisitionShareBasedCompensationAverageExerciseAwardPrice id="ID_51367_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_UnvestedOptionsMember" unitRef="PerShare">16.21</ci:BusinessAcquisitionShareBasedCompensationAverageExerciseAwardPrice>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice id="ID_51368_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_UnvestedOptionsMember" unitRef="USD">28000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice>
  <ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense id="ID_51369_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_UnvestedOptionsMember" unitRef="USD">9000000</ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense>
  <ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards id="ID_51370_Shares_InThousands" decimals="-3" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_UnvestedOptionsMember" unitRef="Shares">1336000</ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice id="ID_51371_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_RestrictedStockGrantsAndUnitsMember" unitRef="USD">19000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwardsIncludedInPurchasePrice>
  <ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense id="ID_51372_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_RestrictedStockGrantsAndUnitsMember" unitRef="USD">16000000</ci:BusinessAcquisitionShareBasedCompensationPostAcquisitionExpense>
  <ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards id="ID_51373_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_RestrictedStockGrantsAndUnitsMember" unitRef="USD">35000000</ci:BusinessAcquisitionShareBasedCompensationFairValueOfAwards>
  <ci:BusinessAcquisitionShareBasedCompensationAverageExerciseAwardPrice id="ID_51374_PerShare_2Decimal" decimals="2" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_RestrictedStockGrantsAndUnitsMember" unitRef="PerShare">44.43</ci:BusinessAcquisitionShareBasedCompensationAverageExerciseAwardPrice>
  <ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards id="ID_51375_Shares_InThousands" decimals="-3" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTypeAndPlanNameAxis_RestrictedStockGrantsAndUnitsMember" unitRef="Shares">786000</ci:BusinessAcquisitionShareBasedCompensationNumberOfAwards>
  <ci:CondensedHealthspringBalanceSheetAtAcquisitionDate id="ID_51380" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Investments&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 612&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 492&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Premiums, accounts and notes receivable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 320&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,547&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 795&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 94&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4,860&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Insurance liabilities&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 514&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 208&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Debt&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 326&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total liabilities acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,048&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Net assets acquired&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 293px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:293px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 51px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:51px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,812&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:CondensedHealthspringBalanceSheetAtAcquisitionDate>
  <ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill id="ID_51381_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">795000000</ci:BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount id="ID_51383_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">2547000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesLongTermDebt id="ID_51384_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">326000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesLongTermDebt>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet id="ID_51385_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">3812000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed id="ID_51386_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">1048000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents id="ID_51387_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">492000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired id="ID_51388_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">4860000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAssetsAcquired>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables id="ID_51389_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">320000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities id="ID_51390_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">514000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets id="ID_51391_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">94000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets>
  <ci:BusinessAcquisitionPurchasePriceAllocationDeferredTaxLiabilitiesNoncurrent id="ID_51392_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">208000000</ci:BusinessAcquisitionPurchasePriceAllocationDeferredTaxLiabilitiesNoncurrent>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsMarketableSecurities id="ID_51393_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">612000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssetsMarketableSecurities>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount id="ID_51397_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">711000000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount id="ID_51398_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis_OtherIntangibleAssetsMember" unitRef="USD">84000000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetAmount id="ID_51399_USD_InMillions" decimals="-6" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">795000000</us-gaap:AcquiredFiniteLivedIntangibleAssetAmount>
  <ci:FairValueAndUsefulLivesOfIntangibleAssets id="ID_51429" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 30px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(Dollars in millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Estimated Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:102px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Estimated Useful Life (In Years)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Customer relationships&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;711&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:102px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 374px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;84&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:102px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;3-10&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 374px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:374px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total other intangible assets&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;795&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 13px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:13px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 102px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;border-color:#000000;min-width:102px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:FairValueAndUsefulLivesOfIntangibleAssets>
  <ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife id="ID_51435" contextRef="AS_OF_Jan31_2012_us-gaap_AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_us-gaap_BusinessAcquisitionAxis_HealthspringMember">8 years</ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
  <ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife id="ID_51436" contextRef="AS_OF_Jan31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember_us-gaap_AcquiredFiniteLivedIntangibleAssetsByMajorClassAxis_OtherIntangibleAssetsMember">3-10 years</ci:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
  <ci:ProFormaInformationHealthspring id="ID_51408" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 23px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 192px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:192px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Unaudited&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 23px; text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 192px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:192px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total revenues&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 7,277&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 6,812&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Shareholders' net income&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 381&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 427&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Earnings per share:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; text-align:left;border-color:#000000;min-width:23px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 24px; text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:left;border-color:#000000;min-width:18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Basic&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.33&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.49&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 471px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:471px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Diluted&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 23px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:23px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.32&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 24px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:24px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 18px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:18px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt; 1.46&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:ProFormaInformationHealthspring>
  <us-gaap:BusinessAcquisitionsProFormaRevenue id="ID_51409_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">6812000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss id="ID_51410_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">427000000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted id="ID_51411_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="PerShare">1.46</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic id="ID_51412_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="PerShare">1.49</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted id="ID_51413_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="PerShare">1.32</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:BusinessAcquisitionsProFormaRevenue id="ID_51414_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">7277000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic id="ID_51415_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="PerShare">1.33</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss id="ID_51416_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012_us-gaap_BusinessAcquisitionAxis_HealthspringMember" unitRef="USD">381000000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <ci:BusinessAcquisitionDescriptionOfAcquiredEntityTextBlock id="ID_51434" contextRef="FROM_Nov01_2011_TO_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember">FirstAssist is based in the United Kingdom and provides travel and protection insurance services</ci:BusinessAcquisitionDescriptionOfAcquiredEntityTextBlock>
  <ci:BusinessCombinationReasonForBusinessCombinationTextBlock id="ID_51433" contextRef="FROM_Nov01_2011_TO_Nov30_2011_us-gaap_BusinessAcquisitionAxis_FirstassistMember">the Company expects will enhance its individual business in the U.K. and around the world.</ci:BusinessCombinationReasonForBusinessCombinationTextBlock>
  <us-gaap:TreasuryStockShares id="ID_50708_Shares_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012" unitRef="Shares">77847260</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockShares id="ID_50709_Shares_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2011" unitRef="Shares">80240471</us-gaap:TreasuryStockShares>
  <us-gaap:EarningsPerShareTextBlock id="ID_35842" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Note 4 &amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;E&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;arnings&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; P&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;er&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; S&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;hare&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; (&amp;#8220;EPS&amp;#8221;)&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Basic and diluted earnings per share were computed as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(Dollars in millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 118px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:118px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Basic&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Dilution&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shareholders' net income &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 371&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 371&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shares &lt;/font&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 285,159&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 285,159&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Common stock equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,840&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,840&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 285,159&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,840&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 288,999&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.30&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.02)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.28&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shareholders' net income &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 413&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 413&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shares &lt;/font&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 270,377&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 270,377&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Common stock equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,496&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 270,377&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 273,873&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.02)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.51&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;I&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;n 2012, the Company adopted&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, as required,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;amended accounting guidance for deferred acquisition costs&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;by selecting&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; retrospective adjustment of prior periods.  See Note 2 for the effect of this new guidance on previously reported EPS amounts.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect would have increased diluted earnings per share (antidilutive) as their exercise price was greater than the average share price of the Company's common stock for the period.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 148px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:148px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Three Months Ended &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 148px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:148px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Antidilutive options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;3.8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;4.1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Company held &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;77,847,260&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shares of common stock in Treasur&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;y as of March 31, 2012, and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;80,240,471&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shares as of March 31, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
  <ci:ScheduleOfEarningsPerShareBasicAndDilutedByCommonClassTextBlock id="ID_36690" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Effect of &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(Dollars in millions, except per share amounts)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 118px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:118px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Basic&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 95px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:95px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Dilution&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Three Months Ended March 31,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shareholders' net income &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 371&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 371&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shares &lt;/font&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 285,159&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 285,159&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Common stock equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,840&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,840&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 285,159&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,840&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 288,999&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.30&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.02)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.28&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shareholders' net income &lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 413&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 413&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Shares &lt;/font&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;(in thousands):&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Weighted average&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 270,377&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 270,377&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 425px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Common stock equivalents&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 20px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,496&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Total shares&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 270,377&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 273,873&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 425px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:425px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;EPS&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 43px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:43px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 20px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:20px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (0.02)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1.51&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:ScheduleOfEarningsPerShareBasicAndDilutedByCommonClassTextBlock>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_36691_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">3840000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_36692_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">3840000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_36693_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="PerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_36694_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">285159000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_36695_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">3840000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_36696_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">288999000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_36697_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="PerShare">1.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_36698_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">270377000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_36699_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">270377000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_36700_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="PerShare">1.53</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_36701_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">3496000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_36702_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="Shares">3496000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_36703_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EffectOfDilutionMember" unitRef="PerShare">-0.02</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_36704_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">270377000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements id="ID_36705_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">3496000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_36706_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="Shares">273873000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_36707_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2011_TO_Mar31_2011_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareDilutedMember" unitRef="PerShare">1.51</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic id="ID_36708_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">285159000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <ci:WeightedAverageNumberOfCommonSharesOutstanding id="ID_36709_Shares_InThousands" decimals="-3" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="Shares">285159000</ci:WeightedAverageNumberOfCommonSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare id="ID_36710_PerShare_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012_ci_EarningsPerShareBasicDilutedByCommonClassAxis_EarningsPerShareBasicMember" unitRef="PerShare">1.30</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock id="ID_35991" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 148px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:148px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Three Months Ended &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 148px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:148px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 567px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:567px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Antidilutive options&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;3.8&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 74px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:74px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;4.1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="ID_36659_Shares_InMillions1Decimal" decimals="-5" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Shares">3800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="ID_36660_Shares_InMillions1Decimal" decimals="-5" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="Shares">4100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <ci:AfterTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome id="ID_51267_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Mar31_2011" unitRef="USD">22000000</ci:AfterTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome>
  <ci:AfterTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome id="ID_51268_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">38000000</ci:AfterTaxImpactOfPriorYearDevelopmentOnShareholdersNetIncome>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthDisclosureTextBlock id="ID_36891" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;N&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ote&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&amp;#8212; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;H&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ealth&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;are&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; M&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;edical&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; C&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;laims &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;P&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ayable&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Medical claims payable for the Health Care segment reflects estimates of the ultimate cost of claims that have been incurred but not yet reported, those&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; that &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;have been reported but not yet paid (reported claims in process) and other medical expense payable, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that primarily comprise&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; accruals for incentives and oth&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;er amounts payable to health care professionals&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and facilities&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; Incurred but not yet reported &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;is&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; the majority of the reserve balance as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred but not yet reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,416&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 952&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Reported claims in process&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 129&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Physician Incentives and other medical expense payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 112&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Medical claims payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,698&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Activity in medical claims payable was as follows:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 188px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:188px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;For the period ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,095&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,246&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 194&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 236&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 901&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,010&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 3px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 5px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Acquired HealthSpring balances, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 510&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,172&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,308&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (135)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (126)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total incurred&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,037&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,182&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Paid claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,002&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,450&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 950&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 841&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total paid&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,952&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,291&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending Balance, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 901&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add:  Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 202&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 194&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending Balance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,698&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to cover incurred but not reported and pending claims for minimum premium products and certain administrative services only business where the right of offset d&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;oes not exist.&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;See Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;11&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for additio&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;nal information on reinsurance.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;three months ended&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;March 31, 2012&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, actual experience differed from the Company&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;'s key assumptions resulting in favorable &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;incurred claims related to prior years' medical claims payable of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;135&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1.6%&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of the current year incurred claims as reported for the year ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. Actual completion factors resulted in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;a reduction&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in medical claims payable of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;60&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of the current year incurred claims as reported for the year ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2011 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;fo&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;r the insured book of business. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Actual medical cost trend resulted in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;a reduction&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in medical clai&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ms payable of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;75&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0.9&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;of the current year incurred claims as reported for the year ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for the insured book of business.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;For the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;year ended December 31, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, actual experience differed from the Company&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;'&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s key assumptions, resulting in favorable incurred claims related to prior years' medical claims payable of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;126&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% of the current year incurred claims as reported for the year ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Actual completion factors resulted in a reduction of the medical claims payable of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;87&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;1.0&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% of the current year incurred claims as reported for the year ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for the insured book of busines&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s.&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Actual medical cost trend resulted in a reduction of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the medical claims payable of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;39&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million, or &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;0&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% of the current year incurred claims as reported for the year ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2010&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for the insured book of business.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The favorable impact&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in 2012 and 2011 relating to completion factor&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; medical cost trend variances are&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; primarily due to the release of the provision for mode&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;rately adverse conditions, that&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; is a component of the assumptions for both completion factors and medical cost trend, established for claims incurred related to prior years.&amp;#160;This release was substantially offset by the provision for moderately adverse conditions established for claims incurred related to the current year.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The corresponding impact of prior year development on &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income was&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;38&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;three months ended March 31, 2012 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;compared with $22 million for the &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;three months ended &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;March 31, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The favorable effect of prior year development on net income in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2012 and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2011 primarily reflects continued low utilization of medical services. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The change in the amount of the incurred claims related to prior years in the medical claims payable liability does not directly correspond to an incr&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ease or decrease in the Company'&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;shareholders' &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;net income recognized for the following reasons:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;First, the Company consistently recognizes the actuarial best estimate of the ultimate liability within a level of confidence, as required by actuarial standards of practice, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; require the liabilities be adequate under moderately adverse conditions.&amp;#160;As the Company establishes the liability for each incurral year, the Company ensures that its assumptions appropriately consider moderately adverse conditions. When a portion of the development related to the prior year incurred claims is offset by an increase determined appropriate to address moderately adverse conditions for the current year incurred claims, the Company does not consider that offset amount as having any impact on shareholders' net income.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Second, as a result of the adoption of the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; commercial&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; minimum medical loss ratio (MLR) provisions of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Patient Protection and Affordable Care Act&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; in 2011, changes in &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;medical claim estimates&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;due to prior year development may be offset by a change in the MLR rebate accrual.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Third&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;changes in reserves for the Company&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;'&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s retrospectively experience-rated business do not always impact shareholders' net income.  For the Company's retrospectively experience-rated business only adjustments to medical claims payable on accounts in deficit affect shareholders' net income. An increase or decrease to medical claims payable on accounts in deficit, in effect, accrues to the Company and directly impacts shareholders' net income. An account is in deficit when the accumulated medical costs and administrative charges, including profit charges, exceed the accumulated premium received. Adjustments to medical claims payable on accounts in surplus accrue directly to the policyholder with no impact on the Company's shareholders' net income. An account is in surplus when the accumulated premium received exceeds the accumulated medical costs and administrative charges, including profit charges.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The determination of liabilities for Health Care &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;medical claims payable requires &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company to make critical accounting estimates.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; See Note 2(N&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;) to the Consolidated Financial Statements in the Company's 2011 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Form &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;10-K.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthDisclosureTextBlock>
  <ci:MedicalClaimsPayableSummaryTextBlock id="ID_35993" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred but not yet reported&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,416&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 952&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Reported claims in process&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 129&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Physician Incentives and other medical expense payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 112&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 14&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;Medical claims payable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,698&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:MedicalClaimsPayableSummaryTextBlock>
  <ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount id="ID_36051_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">1416000000</ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount>
  <ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount id="ID_36052_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">952000000</ci:MedicalClaimsPayableLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIbnrClaimsAmount>
  <ci:MedicalClaimsPayableOtherMedicalExpensePayable id="ID_36055_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">112000000</ci:MedicalClaimsPayableOtherMedicalExpensePayable>
  <ci:MedicalClaimsPayableOtherMedicalExpensePayable id="ID_36056_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">14000000</ci:MedicalClaimsPayableOtherMedicalExpensePayable>
  <ci:MedicalClaimsPayableReportedClaimsInProcess id="ID_51260_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">170000000</ci:MedicalClaimsPayableReportedClaimsInProcess>
  <ci:MedicalClaimsPayableReportedClaimsInProcess id="ID_51261_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">129000000</ci:MedicalClaimsPayableReportedClaimsInProcess>
  <ci:ScheduleOfIncreaseDecreaseInlLabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseTextBlock id="ID_36904" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 188px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:188px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;For the period ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1,&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,095&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,246&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less:  Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 194&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 236&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 901&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,010&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 3px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 5px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Acquired HealthSpring balances, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 510&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Incurred claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,172&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,308&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (135)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (126)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total incurred&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3,037&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,182&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Paid claims related to:&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Current year&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,002&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 7,450&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Prior years&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 950&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 841&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;   Total paid&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,952&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 8,291&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending Balance, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,496&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 901&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add:  Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 202&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 194&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending Balance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,698&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:ScheduleOfIncreaseDecreaseInlLabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseTextBlock>
  <ci:MedicalReinsuranceAndOtherAmountRecoverables id="ID_36905_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">236000000</ci:MedicalReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable id="ID_36906_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1010000000</ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear id="ID_36907_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">8308000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears id="ID_36908_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">-126000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears>
  <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare id="ID_36909_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">8182000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear id="ID_36910_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">7450000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears id="ID_36911_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">841000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid id="ID_36912_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">8291000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid>
  <ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable id="ID_36913_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">901000000</ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable>
  <ci:MedicalReinsuranceAndOtherAmountRecoverables id="ID_36914_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">194000000</ci:MedicalReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear id="ID_36915_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">3172000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears id="ID_36916_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-135000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears>
  <ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear id="ID_36917_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">2002000000</ci:LiabilityForUnpaidMedicalClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears id="ID_36918_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">950000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaidPriorYears>
  <ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid id="ID_36919_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">2952000000</ci:LiabilityForUnpaidMedicalClaimsAndMedicalClaimsAdjustmentExpenseMedicalClaimsPaid>
  <ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable id="ID_36920_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">1496000000</ci:LiabilityForMedicalClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceAndOtherAmountsRecoverable>
  <ci:MedicalReinsuranceAndOtherAmountRecoverables id="ID_36921_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">202000000</ci:MedicalReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth id="ID_37373_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2010" unitRef="USD">1246000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealth>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthAcquired id="ID_51262_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">0</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthAcquired>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthAcquired id="ID_51263_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">510000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseHealthAcquired>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage id="ID_37306_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="Pure">0.01</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions id="ID_36674_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-135000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions id="ID_36675_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">-126000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptions>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends id="ID_36685_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-75000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors id="ID_36686_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">-60000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends id="ID_37356_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">-39000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrends>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors id="ID_37357_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">-87000000</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactors>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage id="ID_37463_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.009</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage id="ID_37464_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.007</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareCompletionFactorsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptionsPercentage id="ID_37465_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.016</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptionsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage id="ID_51264_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="Pure">0.005</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareMedicalCostTrendsPercentage>
  <ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptionsPercentage id="ID_51266_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="Pure">0.015</ci:PolicyholderBenefitsAndClaimsIncurredHealthCareActualExperienceDifferenceFromAssumptionsPercentage>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50644_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">18000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50645_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">11000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:GuaranteedMinimumDeathBenefitMutualFundInvestmentBalance id="ID_50646_USD_InBillions1Decimal" decimals="-8" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">14500000000</ci:GuaranteedMinimumDeathBenefitMutualFundInvestmentBalance>
  <ci:GuaranteedMinimumDeathBenefitMutualFundInvestmentBalance id="ID_50647_USD_InBillions1Decimal" decimals="-8" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">13800000000</ci:GuaranteedMinimumDeathBenefitMutualFundInvestmentBalance>
  <ci:GuaranteedMinimumDeathBenefitDeathBenefitCoverageInForce id="ID_50648_USD_InBillions1Decimal" decimals="-8" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">5400000000</ci:GuaranteedMinimumDeathBenefitDeathBenefitCoverageInForce>
  <ci:GuaranteedMinimumDeathBenefitDeathBenefitCoverageInForce id="ID_50649_USD_InBillions1Decimal" decimals="-8" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">4300000000</ci:GuaranteedMinimumDeathBenefitDeathBenefitCoverageInForce>
  <ci:GuaranteedMinimumDeathBenefitsTotalContractholders id="ID_50650_USD_AsShown" decimals="INF" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">470000</ci:GuaranteedMinimumDeathBenefitsTotalContractholders>
  <ci:GuaranteedMinimumDeathBenefitsTotalContractholders id="ID_50651_USD_AsShown" decimals="INF" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">480000</ci:GuaranteedMinimumDeathBenefitsTotalContractholders>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50652_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">70000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50653_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningEquityMarketVolatilityImpactsMember" unitRef="USD">34000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50654_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningInterestRateImpactsMember" unitRef="USD">22000000</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50655_USD_AsShown" decimals="INF" contextRef="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningOverallMarketDeclineImpactsMember" unitRef="USD">13</ci:PreTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50656_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">45000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50657_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningEquityMarketVolatilityImpactsMember" unitRef="USD">22000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50658_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningInterestRateImpactsMember" unitRef="USD">15000000</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening id="ID_50659_USD_AsShown" decimals="INF" contextRef="FROM_Jan01_2011_TO_Dec31_2011_ci_GuaranteedMinimumDeathBenefitReserveStrengtheningDriversAxis_GuaranteedMinimumDeathBenefitReserveStrengtheningOverallMarketDeclineImpactsMember" unitRef="USD">8</ci:AfterTaxGuaranteedMinimumDeathBenefitReserveStrengthening>
  <ci:PartialSurrendersEstimateAnnualElectionRateLow id="ID_51235_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0</ci:PartialSurrendersEstimateAnnualElectionRateLow>
  <ci:PartialSurrendersEstimateAnnualElectionRateHigh id="ID_51236_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.15</ci:PartialSurrendersEstimateAnnualElectionRateHigh>
  <ci:VolatilityAssumptionVaryingByEquityFundTypeLow id="ID_51237_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.16</ci:VolatilityAssumptionVaryingByEquityFundTypeLow>
  <ci:VolatilityAssumptionVaryingByEquityFundTypeHigh id="ID_51238_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.25</ci:VolatilityAssumptionVaryingByEquityFundTypeHigh>
  <ci:LapseRateAssumptionLow id="ID_51239_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0</ci:LapseRateAssumptionLow>
  <ci:LapseRateAssumptionHigh id="ID_51240_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.24</ci:LapseRateAssumptionHigh>
  <ci:LapseRateAssumptionHigh id="ID_51241_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.18</ci:LapseRateAssumptionHigh>
  <ci:LapseRateAssumptionLow id="ID_51242_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0</ci:LapseRateAssumptionLow>
  <ci:PartialSurrendersEstimateAnnualElectionRateLow id="ID_51243_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0</ci:PartialSurrendersEstimateAnnualElectionRateLow>
  <ci:PartialSurrendersEstimateAnnualElectionRateHigh id="ID_51244_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.13</ci:PartialSurrendersEstimateAnnualElectionRateHigh>
  <ci:VolatilityAssumptionVaryingByEquityFundTypeHigh id="ID_51269_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.24</ci:VolatilityAssumptionVaryingByEquityFundTypeHigh>
  <ci:VolatilityAssumptionVaryingByEquityFundTypeLow id="ID_51270_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.18</ci:VolatilityAssumptionVaryingByEquityFundTypeLow>
  <ci:VolatilityAssumptionVaryingByBondFundTypeLow id="ID_51271_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.05</ci:VolatilityAssumptionVaryingByBondFundTypeLow>
  <ci:VolatilityAssumptionVaryingByBondFundTypeHigh id="ID_51272_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.07</ci:VolatilityAssumptionVaryingByBondFundTypeHigh>
  <ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeLow id="ID_51273_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0</ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeLow>
  <ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeHigh id="ID_51274_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.01</ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeHigh>
  <ci:VolatilityAssumptionVaryingByBondFundTypeLow id="ID_51275_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.04</ci:VolatilityAssumptionVaryingByBondFundTypeLow>
  <ci:VolatilityAssumptionVaryingByBondFundTypeHigh id="ID_51276_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.1</ci:VolatilityAssumptionVaryingByBondFundTypeHigh>
  <ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeLow id="ID_51277_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.02</ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeLow>
  <ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeHigh id="ID_51278_Pure_2Decimal" decimals="2" contextRef="AS_OF_Dec31_2011" unitRef="Pure">0.02</ci:VolatilityAssumptionVaryingByMoneyMarketFundTypeHigh>
  <ci:LargestCustomerPercentOfReserve id="ID_51470_Pure_2Decimal" decimals="2" contextRef="AS_OF_Mar31_2012" unitRef="Pure">0.7</ci:LargestCustomerPercentOfReserve>
  <ci:GuaranteedMinimumDeathBenefitsDisclosureTextBlock id="ID_51439" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;N&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ote&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;6&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&amp;#8213;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Guaranteed Minimum Death Benefit Contracts&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company had future policy benefit res&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;erves&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; guaranteed minimum death b&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;enefit&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;(&amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMDB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; contracts of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$1.1&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;billion as of March 31, 2012&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $1.2&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;billion as of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2011.&amp;#160;&amp;#160; The determination of liabilities for GMDB requires the Company to make critical accounting estimates.&amp;#160;&amp;#160;The Company estimates its liabilities for GMDB exposures using a&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;n&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; internal model run using many scenarios and based on assumptions regarding lapse, future partial surrenders, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;claim &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;mortality&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (deaths that result in claims)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, interest rates (mean investment performance and discount rate) and volatility.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;These assumptions are based on the Company's experience and future expectations over the long-term period, consistent with the long-term nature of this product.  The Company regularly evaluates these assumptions and changes its estimates if actual experience or other evidence suggests that assumptions should be revised.&amp;#160;&amp;#160;If actual experience differs from the assumptions used in estimating these liabilities, the result could have a material adverse effect on the Company's consolidated results of operations, and in certain situations, could have a material adverse effect on the Company's financial condition.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;In 2000, the Company determined that the GMDB reinsurance business was premium deficient because the recorded future policy benefit reserve was less than the expected present value of future claims and expenses less the expected present value of future premiums and investment income using revised assumptions based on actual and expected experience.  The Company tests for premium deficiency by reviewing its reserve each quarter using current market conditions and its long-term assumptions. Under premium deficiency accounting, if the recorded reserve is determined insufficient, an increase to the reserve is reflected as a charge to current period income. Consistent with GAAP, the Company does not recognize gains on premium deficient long duration products.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;See Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;9&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for further information on the Company's dynamic hedge programs &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that are &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;used to reduce certain equity and interest rate &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;exposure&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; associated with this business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;During the first quarter of 2012, the Company's normal review of reserves resulted in a charge to strengthen GMDB reserves of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$18 million&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;($11&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax) reported in other benefit expenses.  The charge was due to the update of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;long-term &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;assumptions described below, and primarily reflected the decrease in assumed lapses.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Since December 31, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;2011, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the Company has updated the following long-term assumptions for GMDB based on a review of experience:&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="margin-left:36px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The lapse assumption for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the largest client&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of the business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;, that&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; represents approximately 70% of the reserve&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; was updated.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The lapse rate varies depending on contract type, policy duration, and the ratio of the net amount at risk to account value.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;As a result of this update, t&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he overall range of lapses&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the entire block of business&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;changed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; from 0% to 24% at December 31, 2011 to 0% to 18% at March 31, 2012.  The effect of this update was an increase in the reserve.&lt;/font&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;p&gt;&amp;#160;&lt;/p&gt;&lt;/li&gt;&lt;li style="margin-left:36px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The reserves include an estimate for partial surrenders&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;,&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that essentially lock in the death benefit for a particular policy based on annual election rates, depending on the net amount at risk for each policy and whether surrender charges apply.  The election rates were updated from 0%&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;15% at December 31, 2011 to 0%&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;13% at March 31, 2012.  The effect of this update was a decrease in the reserve.&lt;/font&gt;&lt;/li&gt;&lt;li style="margin-left:36px;list-style:disc;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The volatility assumption was updated to use a review of historical weekly returns for each index (e.g. S&amp;amp;P 500) for a 20&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;year period.  Volatility represents the dispersion of historical returns compared to the average historical return (standard deviation) for each index.  The volatility assumption for equity fund types has been updated from 16&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;-&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;25&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;% at December 31, 2011 to 18% -&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; 24% at March 31, 2012; for bond funds from 4% - 10% at December 31, 2011 to 5% - 7% at March 31, 2012; and for money market funds from 2% at December 31, 2011 to 0% - 1% at March 31, 2012.  The degree of correlation between asset classes was also updated.  The effect of these updates was an increase in the reserve.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;During 2011, the Company completed its normal review of reserves (including assumptions) and recorded additional other benefit expenses of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;70&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;45&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax) to strengthen GMDB reserves.  The reserve strengthening was driven primarily by&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; an&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;adverse impact of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;34&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;22&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax) due to volatile equity market conditions, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;adverse &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;interest rate impacts of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;22&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax) reflecting management's consideration of the anticipated impact of continuing low current short-term interest rates and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;adverse impacts of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;overall market declines in the third quarter of $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;13&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million ($&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;8&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; million after-tax), that included an increase in the provision for expected future partial surrenders and declines in the value of contractholders' non-equity investments&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Activity in future policy benefit reserves for the GMDB business was as follows&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 188px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:188px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;For the period ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,138&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 40&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 51&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,157&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,124&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Incurred benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (50)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 138&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Paid benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 32&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 105&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending balance, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,075&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,157&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 38&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 40&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending balance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,081&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,170&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Benefits paid and incurred are net of ceded amounts.&amp;#160;&amp;#160;Incurred benefits reflect the favorable or unfavorable impact of a rising or falling equity market on the li&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ability, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and include &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;charge&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; discussed above&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he aggregate value of the underlying mutual fund investments was $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;14.5&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;billion&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; a&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;March 31, 2012 and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;13.8&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; billion as of&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2011.  T&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;he d&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;eath benefit coverage in force&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; was $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;4.3&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;billion&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as of March 31, 2012&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; and&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;$&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;5.4&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;billion&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as of December 31, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#160;&amp;#160;The death benefit coverage in force represents the excess of the guaranteed benefit amount over the value of the underlying mutual fund investments&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for all contractholders (approximate&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;ly &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;470,000&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as of March 31, 2012 and &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;480,000&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;December 31, 2011&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company has also written reinsurance contracts with issuers of variable annuity contracts that provide annuitants with certain guarantees related to minimum income benefits&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; (&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8220;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;GMIB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;&amp;#8221;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;All reinsured GMIB policies also have a GMDB benefit reinsured by the Company.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; See Note &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;7&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; for further information.&lt;/font&gt;&lt;/p&gt;</ci:GuaranteedMinimumDeathBenefitsDisclosureTextBlock>
  <ci:GuaranteedMinimumDeathBenefitsTextBlock id="ID_35995" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="4"  style="width: 188px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:188px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;For the period ended&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2012&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;2011&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,170&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,138&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 40&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 51&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Balance at January 1, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,157&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,124&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Incurred benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; (50)&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 138&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Paid benefits&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 32&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 105&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending balance, net&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,075&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,157&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Less: Unpaid Claims&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 38&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 40&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 523px; border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Add: Reinsurance and other amounts recoverable&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 44&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 53&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 18px"&gt;&lt;td   style="width: 523px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:523px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Ending balance&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,081&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,170&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ci:GuaranteedMinimumDeathBenefitsTextBlock>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits id="ID_37266_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">1170000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits id="ID_37267_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1138000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits id="ID_37268_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">40000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits id="ID_37269_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">37000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits>
  <ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables id="ID_37270_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">53000000</ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables>
  <ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables id="ID_37271_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">51000000</ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBefenitNet id="ID_37272_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">1157000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBefenitNet>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBefenitNet id="ID_37273_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2010_TO_Dec31_2010" unitRef="USD">1124000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBefenitNet>
  <ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits id="ID_37274_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">-50000000</ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits>
  <ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits id="ID_37275_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">138000000</ci:PolicyholderBenefitsGuaranteedMinimumDeathBenefits>
  <ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit id="ID_37276_USD_InMillions" decimals="-6" contextRef="AS_OF_Mar31_2012" unitRef="USD">32000000</ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit>
  <ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit id="ID_37277_USD_InMillions" decimals="-6" contextRef="AS_OF_Dec31_2011" unitRef="USD">105000000</ci:LiabilityForFuturePolicyBenefitReserveBenefitsPaidGuaranteedMinimumDeathBenefit>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBefenitNet id="ID_37278_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">1075000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBefenitNet>
  <ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits id="ID_37280_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">38000000</ci:LiabilityForClaimsAndClaimsAdjustmentExpenseGuaranteedMinimumDeathBenefits>
  <ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables id="ID_37282_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">44000000</ci:GuaranteedMinimumDeathBenefitsReinsuranceAndOtherAmountRecoverables>
  <ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits id="ID_37284_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">1081000000</ci:LiabilityForFuturePolicyBenefitReservesGuaranteedMinimumDeathBenefits>
  <ci:UnrealizedAppreciationSettlementAnnuity id="ID_50616_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">712000000</ci:UnrealizedAppreciationSettlementAnnuity>
  <ci:UnrealizedAppreciationLevel3SettlementAnnuity id="ID_50617_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">101000000</ci:UnrealizedAppreciationLevel3SettlementAnnuity>
  <ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges id="ID_50619_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">8000000</ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges>
  <ci:OtherDerivativeInterestRateSwapNotHedges id="ID_50620_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">29000000</ci:OtherDerivativeInterestRateSwapNotHedges>
  <ci:UnrealizedAppreciationSettlementAnnuity id="ID_50621_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">826000000</ci:UnrealizedAppreciationSettlementAnnuity>
  <ci:UnrealizedAppreciationLevel3SettlementAnnuity id="ID_50622_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">115000000</ci:UnrealizedAppreciationLevel3SettlementAnnuity>
  <ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges id="ID_50623_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">10000000</ci:OtherDerivativeInterestRateAndForeignCurrencySwapHedges>
  <ci:OtherDerivativeInterestRateSwapNotHedges id="ID_50624_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">35000000</ci:OtherDerivativeInterestRateSwapNotHedges>
  <ci:PercentLevel2InvestmentsForeignBondsBrokerQuote id="ID_50627" contextRef="FROM_Jan01_2012_TO_Mar31_2012">Less than 1</ci:PercentLevel2InvestmentsForeignBondsBrokerQuote>
  <ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts id="ID_50629_USD_InBillions1Decimal" decimals="-8" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">3200000000</ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts>
  <ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts id="ID_50630_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">894000000</ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts>
  <ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts id="ID_50631_USD_InBillions" decimals="-9" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">3000000000</ci:PensionPlanAssetsIncludedInNonGuaranteedSeparateAccounts>
  <ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts id="ID_50632_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">702000000</ci:PensionPlanAssetsIncludedInLevel3NonGuaranteedSeparateAccounts>
  <ci:PercentUnrestrictedContractholderDepositFunds id="ID_50641_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.55</ci:PercentUnrestrictedContractholderDepositFunds>
  <ci:RealizedInvestmentLossesCommercialMortgageLoans id="ID_50710_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">2000000</ci:RealizedInvestmentLossesCommercialMortgageLoans>
  <ci:RealizedInvestmentLossesCommercialMortgageLoans id="ID_50711_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">15000000</ci:RealizedInvestmentLossesCommercialMortgageLoans>
  <ci:PercentageOfImpairedCommercialMortgageLoansAndRealEstateEntitiesOfTotalInvestments id="ID_50712" contextRef="FROM_Jan01_2011_TO_Dec31_2011">less than 1</ci:PercentageOfImpairedCommercialMortgageLoansAndRealEstateEntitiesOfTotalInvestments>
  <ci:PercentageOfImpairedCommercialMortgageLoansAndRealEstateEntitiesOfTotalInvestments id="ID_50713" contextRef="FROM_Jan01_2012_TO_Mar31_2012">less than 1</ci:PercentageOfImpairedCommercialMortgageLoansAndRealEstateEntitiesOfTotalInvestments>
  <ci:PercentReinsuredExternallyGuaranteedMinimumIncomeBenefits id="ID_50715_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="Pure">0.55</ci:PercentReinsuredExternallyGuaranteedMinimumIncomeBenefits>
  <ci:PercentLevel2FixedMaturitiesEquitySecurities id="ID_51193_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.93</ci:PercentLevel2FixedMaturitiesEquitySecurities>
  <ci:PercentLevel3FixedMaturitiesEquitySecurities id="ID_51194_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.06</ci:PercentLevel3FixedMaturitiesEquitySecurities>
  <ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld id="ID_51195_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="USD">12000000</ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld>
  <ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld id="ID_51196_USD_InMillions" decimals="-6" contextRef="FROM_Jan01_2011_TO_Dec31_2011" unitRef="USD">40000000</ci:PolicyholderGainsLossesAttributableToInstrumentsStillHeld>
  <ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyLow id="ID_51220_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember" unitRef="Pure">60</ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyLow>
  <ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyHigh id="ID_51221_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember" unitRef="Pure">680</ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyHigh>
  <ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyWeightedAverage id="ID_51222_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember" unitRef="Pure">80</ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyWeightedAverage>
  <ci:WeightingOfCreditSpreadsAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyLow id="ID_51223_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember" unitRef="Pure">60</ci:WeightingOfCreditSpreadsAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyLow>
  <ci:WeightingOfCreditSpreadsAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyHigh id="ID_51224_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember" unitRef="Pure">5200</ci:WeightingOfCreditSpreadsAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyHigh>
  <ci:WeightingOfCreditSpreadsAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyWeightedAverage id="ID_51225_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesMember" unitRef="Pure">465</ci:WeightingOfCreditSpreadsAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyWeightedAverage>
  <ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyLow id="ID_51226_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedCorporateBondsMember" unitRef="Pure">10</ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyLow>
  <ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyHigh id="ID_51227_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedCorporateBondsMember" unitRef="Pure">475</ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyHigh>
  <ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyWeightedAverage id="ID_51228_Pure_AsShown" decimals="INF" contextRef="AS_OF_Mar31_2012_ci_FairValueLevel3AssetsPricedUsingSignificantUnobservableInputsDevelopedDirectlyByCompanyAxis_FinancialInstrumentsOwnedCorporateBondsMember" unitRef="Pure">235</ci:LiquidityAdjustmentUsedInPricingLevel3SecuritiesDirectlyDevelopedByCompanyWeightedAverage>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsGuaranteedClaimInterestRate id="ID_50597_Pure_4Decimal" decimals="4" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.0161</ci:GuaranteedMinimumIncomeBenefitsAssumptionsGuaranteedClaimInterestRate>
  <ci:GuaranteedMinimumIncomeBenefitsContractuallyGuaranteedClaimInterestRateFloor id="ID_50598_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.03</ci:GuaranteedMinimumIncomeBenefitsContractuallyGuaranteedClaimInterestRateFloor>
  <ci:MutualFundInvestmentsPercentModeledOnInsufficientMarketObservableData id="ID_50599_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.5</ci:MutualFundInvestmentsPercentModeledOnInsufficientMarketObservableData>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateLowEnd id="ID_50600_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.18</ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateHighEnd id="ID_50601_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.36</ci:GuaranteedMinimumIncomeBenefitsAssumptionsEquityFundVolatilityRateHighEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateLowEnd id="ID_50602_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.06</ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateHighEnd id="ID_50603_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.09</ci:GuaranteedMinimumIncomeBenefitsAssumptionsBondFundVolatilityRateHighEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateLowEnd id="ID_50604_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0</ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateHighEnd id="ID_50605_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.01</ci:GuaranteedMinimumIncomeBenefitsAssumptionsMoneyMarketFundVolatilityRateHighEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeMortalityRate id="ID_50606_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.7</ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeMortalityRate>
  <ci:AnnualPercentImprovementTableGroupAnnuityMortality id="ID_50607_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.01</ci:AnnualPercentImprovementTableGroupAnnuityMortality>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProducTandGuaranteeLapseRateLowEnd id="ID_50608_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.01</ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProducTandGuaranteeLapseRateLowEnd>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeLapseRateHighEnd id="ID_50609_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.12</ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeLapseRateHighEnd>
  <ci:ProbabilityOfAnnuitizingVariableAnnuityImmediatelyAfterWaitingPeriodExpiration id="ID_50610_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.8</ci:ProbabilityOfAnnuitizingVariableAnnuityImmediatelyAfterWaitingPeriodExpiration>
  <ci:ProbabilityOfAnnuitizingVariableAnnuityInSecondAnnualBenefitOpportunity id="ID_50611_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.35</ci:ProbabilityOfAnnuitizingVariableAnnuityInSecondAnnualBenefitOpportunity>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityLow id="ID_50612_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">5</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityLow>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityHigh id="ID_50613_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">120</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityHigh>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetLow id="ID_50614_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">35</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetLow>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetHigh id="ID_50615_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">125</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetHigh>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeLapseRateAverage id="ID_51289_Pure_3Decimal" decimals="3" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.024</ci:GuaranteedMinimumIncomeBenefitsAssumptionsByProductAndGuaranteeLapseRateAverage>
  <ci:WeightedAverageAnnualAnnuityElectionRate id="ID_51290_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.12</ci:WeightedAverageAnnualAnnuityElectionRate>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityAverage id="ID_51291_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">45</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsLiablityAverage>
  <ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetAverage id="ID_51292_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">70</ci:AdditionalSpreadOverLiborGuaranteedMinimumIncomeBenefitsAssetAverage>
  <ci:GuaranteedMinimumIncomeBenefitsAssumptionsRequiredReturnOnCapital id="ID_51293_Pure_2Decimal" decimals="2" contextRef="FROM_Jan01_2012_TO_Mar31_2012" unitRef="Pure">0.1</ci:GuaranteedMinimumIncomeBenefitsAssumptionsRequiredReturnOnCapital>
  <us-gaap:FairValueMeasurementInputsDisclosureTextBlock id="ID_37338" contextRef="FROM_Jan01_2012_TO_Mar31_2012">&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;N&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ote&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;7&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;&amp;#8213;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company carries certain financial instruments at fair value in the financial statements including fixed maturities, equity securities, short-term investments and derivatives.&amp;#160;&amp;#160;Other financial instruments are measured at fair value under certain conditions, such as when impaired.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Fair value is defined as the price at which an asset could be exchanged in an orderly transaction between market participants at the balance sheet date.&amp;#160;&amp;#160;A liability's fair value is defined as the amount that would be paid to transfer the liability to a market participant, not the amount that would be paid to settle the liability with the creditor.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;Fair values are based on quoted market prices when available.&amp;#160;&amp;#160;When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality.&amp;#160;&amp;#160;In instances where there is little or no market activity for the same or similar instruments, the Company estimates fair value using methods, models and assumptions that the Company believes a hypothetical market participant would use to determine a current transaction price.&amp;#160;&amp;#160;These valuation techniques involve some level of estimation and judgment by the Company which becomes significant with increasingly complex instruments or pricing models.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The Company's financial assets and liabilities carried at fair value have been classified based upon a hierarchy defined by GAAP.&amp;#160;&amp;#160;The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;significant &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;unobservable inputs (Level 3). An asset's or a liability's classification is based on the lowest level of input that is significant to its measurement.&amp;#160;&amp;#160;For example, a financial asset or liability carried at fair value would be classified in Level 3 if unobservable inputs were significant to the instrument's fair value, even though the measurement may be derived using inputs that are both observable (Levels 1 and 2) and unobservable (Level 3)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The prices the Company uses to value its investment assets are representative of prices that would be received to sell the assets at the measurement date (exit prices) and are classified appropriately in the fair value hierarchy.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company performs ongoing analyses of prices used to value the Company's invested assets to determine that they represent appropriate estimates of fair value.  This process involves quantitative and qualitative analysis &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that is overseen by the Company's investment professionals, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;including reviews of pricing methodologies, judgments of valuation inputs, the significance of any unobservable inputs, pricing statistics and trends.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;These reviews are also designed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; to ensure prices do not become stale, have reasonable explanations as to why they have changed from prior valuations, or require additional review &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;for &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;other anomalies.  &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;The Company also performs sample testing of sales values to confirm the accuracy&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; of prior fair value estimates.  Exceptions identified during these processes indicate that adjustments to prices are infrequent and do not significantly impact valuations.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;"&gt;Financial &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;A&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;ssets and Financial &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;L&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;iabilities &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;Carried&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt; at &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;F&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;air &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;V&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;"&gt;alue &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;"&gt;The following table&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;s&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; provide information as of &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;March 31, 2012&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;and December 31, 2011 &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;about the Company's financial assets and liabilities &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;carried&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; at&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; fair value&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;.&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;Similar&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt; disclosures for separate account assets, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;that &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;are also recorded at fair value on the Company's Consolidated Balance Sheets, are provided separately as gains and losses related to these assets generally accrue directly to &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;policyholders.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;"&gt;  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: left;"&gt;March 31, 2012&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Quoted Prices in Active Markets for Identical Assets
(Level 1)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Significant Other Observable Inputs
(Level 2)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Significant Unobservable Inputs
(Level 3)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Financial assets at fair value:&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Fixed maturities:&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Federal government and agency &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 141&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 705&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 848&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  State and local government&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,524&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,524&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Foreign government&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,254&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 21&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,275&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Corporate &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 10,770&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 438&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 11,208&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Federal agency mortgage-backed &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 158&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 158&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Other mortgage-backed &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 88&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 89&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Other asset-backed &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 368&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 579&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 947&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total fixed maturities&lt;/font&gt;&lt;sup&gt; (1)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 141&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 15,867&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,041&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17,049&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Equity securities &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 4&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 72&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 31&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 107&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;    Subtotal&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 145&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 15,939&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,072&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17,156&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Short-term investments&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 187&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 187&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;GMIB assets&lt;/font&gt;&lt;sup&gt; (2)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 617&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 617&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other derivative assets&lt;/font&gt;&lt;sup&gt; (3)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 37&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total financial assets at fair value, excluding separate accounts&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 145&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,163&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,689&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17,997&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Financial liabilities at fair value:&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;GMIB liabilities &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,162&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,162&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other derivative liabilities&lt;/font&gt;&lt;sup&gt; (3)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 31&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 31&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 334px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total financial liabilities at fair value&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 31&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,162&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,193&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;margin-left:0px;"&gt;(1) Fixed maturities include&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;d&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;712&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;million of net appreciation required to adjust future policy benefits for the run-off settlement annuity business including $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;101&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;million of appreciation for securities classified in Level 3.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;margin-left:0px;"&gt;(2) The &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;GMIB&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; assets represent retrocessional contracts in place fr&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;om two external reinsurers that&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; cover &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;55&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;% of the&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; exposures on these contracts.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;margin-left:0px;"&gt;(3)&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; Other derivative assets included&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;8&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; million of interest rate and foreign currency swaps qualifying as cash flow hedges and $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;29&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;million of interest rate swaps not designated as accounting hedges.&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;  Other derivative liabilities reflect&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;ed&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; foreign &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;currency&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; and interest rate swaps qualifying as cash flow hedges.  See Note 9 for additional information.  &lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&amp;#160;&lt;/p&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;margin-top:20px;"&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;December 31, 2011&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-STYLE: italic;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;(In millions)&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Quoted Prices in Active Markets for Identical Assets
(Level 1)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Significant Other Observable Inputs
(Level 2)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Significant Unobservable Inputs
(Level 3)&lt;/font&gt;&lt;/td&gt;&lt;td colspan="2"  style="width: 94px; border-top-style:solid;border-top-width:2px;border-bottom-style:solid;border-bottom-width:1px;text-align:center;background-color:#FFFFFF;border-color:#000000;min-width:94px;"&gt;&lt;font style="FONT-WEIGHT: bold;FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: center;"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Financial assets at fair value:&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Fixed maturities:&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Federal government and agency &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 217&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 738&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 958&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  State and local government&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,456&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 2,456&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Foreign government&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,251&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 23&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,274&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Corporate &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 10,132&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 381&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 10,513&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Federal agency mortgage-backed &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 9&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Other mortgage-backed &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 79&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;  Other asset-backed &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 363&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 564&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 927&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 17px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total fixed maturities&lt;/font&gt;&lt;sup&gt; (1)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 217&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 15,028&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 972&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,217&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Equity securities &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 3&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 67&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 30&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 100&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;    Subtotal&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 220&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 15,095&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,002&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 16,317&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Short-term investments&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 225&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 225&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;GMIB assets&lt;/font&gt;&lt;sup&gt; (2)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 712&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 712&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other derivative assets&lt;/font&gt;&lt;sup&gt; (3)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 45&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 45&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total financial assets at fair value, excluding separate accounts&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 220&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 15,365&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,714&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:double;border-bottom-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 17,299&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Financial liabilities at fair value:&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:double;border-top-width:3px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;GMIB liabilities &lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,333&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,333&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 15px"&gt;&lt;td   style="width: 334px; text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Other derivative liabilities&lt;/font&gt;&lt;sup&gt; (3)&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 30&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td   style="width: 75px; border-bottom-style:solid;border-bottom-width:1px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 30&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 16px"&gt;&lt;td   style="width: 334px; border-bottom-style:solid;border-bottom-width:2px;text-align:left;background-color:#FFFFFF;border-color:#000000;min-width:334px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;"&gt;Total financial liabilities at fair value&lt;/font&gt;&lt;sup&gt;&lt;/sup&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; -&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 30&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,333&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 19px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:19px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td   style="width: 75px; border-top-style:solid;border-top-width:1px;border-bottom-style:solid;border-bottom-width:2px;text-align:right;background-color:#FFFFFF;border-color:#000000;min-width:75px;"&gt;&lt;font style="FONT-FAMILY: Times New Roman;FONT-SIZE: 8pt;COLOR: #000000;TEXT-ALIGN: right;"&gt; 1,363&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style='margin-top: 0pt; margin-bottom: 0pt;'&gt;&lt;/p&gt;&lt;p style='margin-top:12pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;margin-left:0px;"&gt;(1) Fixed maturities include&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;d&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;826&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; million of net appreciation required to adjust future policy benefits for the run-off settlement annuity business including $&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt;115&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;"&gt; million of appreciation for securities classified in Level 3.&lt;/font&gt;&lt;/p&gt;&lt;p style='margin-top:0pt; margin-bottom:0pt'&gt;&lt;font style="font-family:Times New Roman;font-size:8pt;font-style:italic;margin-